| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.829 | 0.004 | 0.829 | Hypolipemic | 0.765 0.004 DBMET01203 0.748 0.004 DBMET00068 0.756 0.004 DBMET01204 0.798 0.004 DBMET00069 0.723 0.004 DBMET01205 0.751 0.004 DBMET01178 0.702 0.005 DBMET01179 0.713 0.005 DBMET01206 0.309 0.046 DBMET01180 0.269 0.059 DBMET01181 | ||
| 0.707 | 0.007 | 0.765 | Cholesterol antagonist | 0.73 0.006 DBMET01203 0.688 0.009 DBMET00068 0.733 0.006 DBMET01204 0.554 0.025 DBMET00069 0.295 0.094 DBMET00070 0.592 0.02 DBMET01205 0.765 0.005 DBMET01178 0.518 0.03 DBMET01179 0.596 0.019 DBMET01206 0.667 0.011 DBMET01180 0.595 0.019 DBMET01181 | DBMET01178 | |
| 0.645 | 0.004 | 0.662 | Lipid peroxidase inhibitor | 0.662 0.003 DBMET01203 0.506 0.005 DBMET00068 0.648 0.004 DBMET01204 0.62 0.004 DBMET00069 0.646 0.004 DBMET01205 0.538 0.005 DBMET01178 0.468 0.006 DBMET01179 0.629 0.004 DBMET01206 | DBMET01203 | |
| 0.404 | 0.001 | 0.433 | Squalene epoxidase inhibitor | 0.433 0.001 DBMET01203 0.36 0.001 DBMET00068 0.426 0.001 DBMET01204 0.217 0.002 DBMET00069 0.095 0.006 DBMET00070 0.265 0.002 DBMET01205 0.3 0.002 DBMET01178 0.165 0.003 DBMET01179 0.253 0.002 DBMET01206 0.081 0.009 DBMET01180 0.069 0.014 DBMET01181 | DBMET01203 | |
| 0.35 | 0.002 | 0.35 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.186 0.003 DBMET01203 0.251 0.002 DBMET00068 0.196 0.003 DBMET01204 0.057 0.008 DBMET00069 0.037 0.025 DBMET00070 0.036 0.027 DBMET01205 0.121 0.004 DBMET01178 0.045 0.015 DBMET01179 0.037 0.025 DBMET01206 | ||
| 0.339 | 0.028 | 0.466 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.235 0.068 DBMET01203 0.264 0.054 DBMET00068 0.234 0.069 DBMET01204 0.466 0.005 DBMET00070 0.218 0.078 DBMET01178 | DBMET00070 | |
| 0.32 | 0.009 | 0.32 | Cyclin-dependent kinase 7 inhibitor | 0.199 0.034 DBMET01203 0.278 0.016 DBMET00068 0.195 0.036 DBMET01204 0.128 0.077 DBMET00069 0.193 0.036 DBMET01178 0.119 0.086 DBMET01179 | ||
| 0.355 | 0.083 | 0.527 | GABA C receptor rho-3 antagonist | 0.352 0.085 DBMET01203 0.218 0.186 DBMET00068 0.357 0.082 DBMET01204 0.507 0.024 DBMET00069 0.499 0.026 DBMET00070 0.505 0.025 DBMET01205 0.247 0.157 DBMET01178 0.376 0.073 DBMET01179 0.509 0.023 DBMET01206 0.527 0.019 DBMET01180 0.472 0.034 DBMET01181 | DBMET01180 | |
| 0.378 | 0.121 | 0.639 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.27 0.256 DBMET00068 0.271 0.255 DBMET01204 0.395 0.105 DBMET00069 0.639 0.004 DBMET00070 0.267 0.26 DBMET01205 0.266 0.262 DBMET01178 0.288 0.229 DBMET01179 0.288 0.229 DBMET01206 0.614 0.005 DBMET01180 0.475 0.046 DBMET01181 | DBMET00070 | |
| 0.317 | 0.071 | 0.387 | Caspase 3 stimulant | 0.387 0.048 DBMET01203 0.272 0.095 DBMET00068 0.382 0.05 DBMET01204 0.311 0.073 DBMET00069 0.349 0.059 DBMET00070 0.384 0.049 DBMET01205 0.273 0.094 DBMET01178 0.267 0.099 DBMET01179 0.379 0.05 DBMET01206 0.261 0.103 DBMET01181 | DBMET01203 | |
| 0.284 | 0.052 | 0.41 | Potassium channel blocker | 0.41 0.021 DBMET00068 0.295 0.048 DBMET01179 | DBMET00068 | |
| 0.233 | 0.013 | 0.276 | Alpha 2 adrenoreceptor antagonist | 0.267 0.01 DBMET01203 0.082 0.064 DBMET00068 0.276 0.009 DBMET01204 0.112 0.04 DBMET00069 0.134 0.032 DBMET01205 0.139 0.03 DBMET01206 | DBMET01204 | |
| 0.263 | 0.045 | 0.263 | ErbB-1 antagonist | 0.211 0.078 DBMET01203 0.216 0.074 DBMET00068 0.222 0.069 DBMET01204 0.206 0.083 DBMET00069 0.17 0.132 DBMET01205 0.189 0.103 DBMET01178 0.174 0.126 DBMET01179 0.18 0.115 DBMET01206 | ||
| 0.226 | 0.011 | 0.301 | Alpha 2a adrenoreceptor antagonist | 0.287 0.007 DBMET01203 0.068 0.06 DBMET00068 0.301 0.007 DBMET01204 0.139 0.025 DBMET00069 0.181 0.017 DBMET01205 0.188 0.015 DBMET01206 | DBMET01204 | |
| 0.208 | 0.005 | 0.208 | Adrenaline uptake inhibitor | 0.123 0.014 DBMET01203 0.112 0.016 DBMET00068 0.125 0.013 DBMET01204 0.116 0.015 DBMET00069 0.062 0.043 DBMET01205 0.095 0.02 DBMET01178 0.054 0.052 DBMET01179 0.065 0.04 DBMET01206 | ||
| 0.236 | 0.049 | 0.395 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.343 0.014 DBMET01203 0.223 0.056 DBMET00068 0.33 0.016 DBMET01204 0.154 0.139 DBMET00069 0.232 0.051 DBMET00070 0.25 0.043 DBMET01205 0.243 0.046 DBMET01178 0.233 0.051 DBMET01206 0.395 0.008 DBMET01180 0.356 0.012 DBMET01181 | DBMET01180 | |
| 0.266 | 0.09 | 0.37 | Immunostimulant | 0.341 0.067 DBMET01203 0.283 0.084 DBMET00068 0.326 0.072 DBMET01204 0.302 0.078 DBMET00069 0.268 0.089 DBMET00070 0.37 0.059 DBMET01205 0.261 0.092 DBMET01178 0.321 0.073 DBMET01179 0.356 0.062 DBMET01206 0.254 0.095 DBMET01180 0.259 0.092 DBMET01181 | DBMET01205 | |
| 0.216 | 0.05 | 0.272 | Growth factor agonist | 0.17 0.102 DBMET01203 0.251 0.031 DBMET00068 0.171 0.1 DBMET01204 0.242 0.035 DBMET00069 0.151 0.139 DBMET00070 0.186 0.078 DBMET01205 0.17 0.101 DBMET01178 0.272 0.023 DBMET01179 0.187 0.077 DBMET01206 0.178 0.089 DBMET01181 | DBMET01179 | |
| 0.16 | 0.003 | 0.16 | Squalene synthetase inhibitor | 0.14 0.004 DBMET01203 0.147 0.004 DBMET00068 0.138 0.004 DBMET01204 0.153 0.004 DBMET00069 0.131 0.004 DBMET01205 0.137 0.004 DBMET01178 0.14 0.004 DBMET01179 0.128 0.005 DBMET01206 | ||
| 0.199 | 0.065 | 0.275 | 5 Hydroxytryptamine 3E antagonist | 0.184 0.095 DBMET00069 0.275 0.008 DBMET00070 0.221 0.035 DBMET01180 0.243 0.019 DBMET01181 | DBMET00070 | |
| 0.145 | 0.017 | 0.145 | 5 Hydroxytryptamine uptake inhibitor | 0.056 0.049 DBMET00068 | ||
| 0.253 | 0.131 | 0.354 | Vasodilator, coronary | 0.3 0.087 DBMET01203 0.323 0.071 DBMET00068 0.287 0.098 DBMET01204 0.207 0.175 DBMET00070 0.284 0.101 DBMET01178 0.192 0.189 DBMET01179 0.354 0.053 DBMET01180 0.335 0.063 DBMET01181 | DBMET01180 | |
| 0.168 | 0.091 | 0.171 | MAP kinase kinase 5 inhibitor | 0.171 0.083 DBMET00068 | DBMET00068 | |
| 0.195 | 0.12 | 0.353 | DNA damaging | 0.262 0.074 DBMET01203 0.256 0.077 DBMET01204 0.353 0.04 DBMET00070 0.208 0.109 DBMET01205 0.161 0.156 DBMET01178 0.202 0.114 DBMET01206 0.225 0.097 DBMET01180 0.343 0.043 DBMET01181 | DBMET00070 | |
| 0.113 | 0.039 | 0.158 | Calcium antagonist | 0.085 0.059 DBMET00068 0.076 0.067 DBMET00070 0.158 0.02 DBMET01180 0.1 0.048 DBMET01181 | DBMET01180 | |
| 0.087 | 0.015 | 0.087 | Dopamine transporter inhibitor | 0.048 0.034 DBMET01203 0.044 0.038 DBMET00068 0.05 0.032 DBMET01204 | ||
| 0.284 | 0.212 | 0.751 | Caspase 9 stimulant | 0.434 0.092 DBMET01203 0.266 0.233 DBMET00068 0.424 0.097 DBMET01204 0.358 0.139 DBMET00069 0.751 0.018 DBMET00070 0.516 0.054 DBMET01205 0.26 0.241 DBMET01178 0.339 0.155 DBMET01179 0.506 0.057 DBMET01206 0.475 0.071 DBMET01180 0.703 0.023 DBMET01181 | DBMET00070 | |
| 0.092 | 0.021 | 0.092 | Dopamine uptake inhibitor | 0.056 0.042 DBMET00068 0.05 0.049 DBMET01204 | ||
| 0.128 | 0.064 | 0.202 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.083 DBMET01203 0.111 0.107 DBMET00068 0.127 0.066 DBMET01204 0.167 0.022 DBMET00069 0.202 0.01 DBMET00070 0.151 0.033 DBMET01205 0.117 0.091 DBMET01178 0.143 0.042 DBMET01179 0.158 0.028 DBMET01206 0.182 0.015 DBMET01180 0.174 0.019 DBMET01181 | DBMET00070 | |
| 0.217 | 0.157 | 0.461 | Vasodilator, peripheral | 0.215 0.16 DBMET01203 0.223 0.151 DBMET00068 0.197 0.18 DBMET01204 0.218 0.156 DBMET00069 0.215 0.159 DBMET01205 0.231 0.143 DBMET01178 0.224 0.15 DBMET01179 0.197 0.179 DBMET01206 0.42 0.049 DBMET01180 0.461 0.037 DBMET01181 | DBMET01181 | |
| 0.086 | 0.028 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.087 0.026 DBMET00069 0.09 0.022 DBMET00070 0.099 0.014 DBMET01180 0.088 0.024 DBMET01181 | DBMET01180 | |
| 0.063 | 0.009 | 0.063 | Growth hormone releasing factor agonist | 0.049 0.013 DBMET00068 0.05 0.013 DBMET00069 0.031 0.025 DBMET01178 0.04 0.018 DBMET01179 | ||
| 0.091 | 0.041 | 0.359 | CYP2A6 inhibitor | 0.073 0.056 DBMET00069 0.359 0.003 DBMET00070 0.114 0.029 DBMET01180 0.129 0.023 DBMET01181 | DBMET00070 | |
| 0.101 | 0.051 | 0.358 | Uric acid excretion stimulant | 0.141 0.027 DBMET01203 0.105 0.048 DBMET00068 0.14 0.027 DBMET01204 0.12 0.038 DBMET00069 0.084 0.076 DBMET00070 0.158 0.021 DBMET01205 0.161 0.02 DBMET01178 0.12 0.038 DBMET01179 0.156 0.021 DBMET01206 0.358 0.004 DBMET01180 0.164 0.019 DBMET01181 | DBMET01180 | |
| 0.17 | 0.121 | 0.352 | Potassium channel (Voltage-sensitive) blocker | 0.352 0.036 DBMET00068 0.175 0.116 DBMET01179 | DBMET00068 | |
| 0.102 | 0.056 | 0.147 | Nitric-oxide synthase inhibitor | 0.147 0.024 DBMET00069 0.114 0.042 DBMET01205 0.108 0.048 DBMET01206 0.09 0.077 DBMET01181 | DBMET00069 | |
| 0.109 | 0.065 | 0.109 | Interleukin 2 antagonist | |||
| 0.2 | 0.157 | 0.265 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.191 0.168 DBMET01203 0.185 0.175 DBMET01204 0.265 0.092 DBMET01180 | DBMET01180 | |
| 0.123 | 0.084 | 0.123 | Calcium channel blocker | |||
| 0.101 | 0.065 | 0.309 | Adenylate kinase inhibitor | 0.101 0.065 DBMET00068 0.157 0.024 DBMET00070 0.133 0.035 DBMET01178 0.309 0.006 DBMET01180 0.218 0.013 DBMET01181 | DBMET01180 | |
| 0.056 | 0.021 | 0.059 | Adenylate cyclase 1 inhibitor | 0.055 0.022 DBMET00069 0.057 0.02 DBMET00070 0.059 0.019 DBMET01180 0.058 0.019 DBMET01181 | DBMET01180 | |
| 0.163 | 0.128 | 0.757 | Aldehyde oxidase inhibitor | 0.338 0.058 DBMET01203 0.268 0.076 DBMET00068 0.326 0.06 DBMET01204 0.757 0.005 DBMET00070 0.233 0.089 DBMET01205 0.215 0.097 DBMET01178 0.184 0.114 DBMET01179 0.225 0.092 DBMET01206 0.721 0.007 DBMET01180 0.58 0.022 DBMET01181 | DBMET00070 | |
| 0.048 | 0.016 | 0.05 | Diamine oxidase inhibitor | 0.035 0.029 DBMET00068 0.045 0.018 DBMET01180 0.05 0.014 DBMET01181 | DBMET01181 | |
| 0.132 | 0.101 | 0.247 | GABA C receptor rho-2 antagonist | 0.192 0.033 DBMET00069 0.197 0.03 DBMET00070 0.177 0.044 DBMET01205 0.155 0.067 DBMET01179 0.174 0.047 DBMET01206 0.247 0.012 DBMET01180 0.205 0.026 DBMET01181 | DBMET01180 | |
| 0.065 | 0.037 | 0.065 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.113 | 0.085 | 0.145 | Acetylcholinesterase inhibitor | 0.145 0.059 DBMET01203 0.142 0.06 DBMET01204 | DBMET01203 | |
| 0.06 | 0.033 | 0.195 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DBMET00068 0.052 0.04 DBMET00069 0.075 0.024 DBMET00070 0.076 0.024 DBMET01178 0.052 0.04 DBMET01179 0.195 0.005 DBMET01180 0.129 0.011 DBMET01181 | DBMET01180 | |
| 0.079 | 0.053 | 0.079 | ErbB-4 antagonist | |||
| 0.093 | 0.068 | 0.189 | Sphingomyelinase inhibitor | 0.099 0.061 DBMET00068 0.087 0.076 DBMET00069 0.116 0.044 DBMET00070 0.093 0.068 DBMET01179 0.144 0.027 DBMET01180 0.189 0.012 DBMET01181 | DBMET01181 | |
| 0.177 | 0.157 | 0.21 | 5 Hydroxytryptamine 1E antagonist | 0.21 0.119 DBMET00070 0.187 0.146 DBMET01180 | DBMET00070 | |
| 0.058 | 0.04 | 0.058 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.105 | 0.091 | 0.105 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.029 | 0.015 | 0.082 | Calcium-sensing receptor agonist | 0.026 0.019 DBMET00068 0.082 0.004 DBMET00069 0.043 0.006 DBMET01205 0.03 0.014 DBMET01178 0.076 0.004 DBMET01179 0.039 0.008 DBMET01206 0.065 0.004 DBMET01180 0.033 0.011 DBMET01181 | DBMET00069 | |
| 0.069 | 0.061 | 0.069 | ErbB-2 antagonist | |||
| 0.022 | 0.015 | 0.023 | Vitamin D receptor antagonist | 0.023 0.014 DBMET00069 0.021 0.019 DBMET01205 0.021 0.019 DBMET01206 | DBMET00069 | |
| 0.121 | 0.116 | 0.203 | Thiol protease inhibitor | 0.179 0.049 DBMET00069 0.155 0.065 DBMET00070 0.164 0.058 DBMET01205 0.156 0.063 DBMET01179 0.17 0.054 DBMET01206 0.203 0.038 DBMET01180 0.151 0.068 DBMET01181 | DBMET01180 | |
| 0.021 | 0.017 | 0.041 | Geranylgeranyltransferase inhibitor | 0.029 0.01 DBMET00069 0.027 0.011 DBMET00070 0.028 0.01 DBMET01180 0.041 0.006 DBMET01181 | DBMET01181 | |
| 0.026 | 0.023 | 0.026 | Motilin receptor antagonist | |||
| 0.033 | 0.032 | 0.033 | Somatostatin 4 agonist | |||
| 0.021 | 0.019 | 0.095 | Retinoid X gamma receptor agonist | 0.021 0.019 DBMET00068 0.033 0.009 DBMET01178 0.095 0.004 DBMET01180 | DBMET01180 | |
| 0.063 | 0.061 | 0.087 | Lipase inhibitor | 0.07 0.054 DBMET01203 0.071 0.053 DBMET01204 0.086 0.037 DBMET00069 0.087 0.036 DBMET01205 0.066 0.058 DBMET01179 0.087 0.036 DBMET01206 | DBMET01206 | |
| 0.025 | 0.024 | 0.041 | Retinoid X gamma receptor antagonist | 0.026 0.021 DBMET00068 0.031 0.011 DBMET01178 0.026 0.021 DBMET01179 0.041 0.004 DBMET01180 | DBMET01180 | |
| 0.037 | 0.037 | 0.058 | CF transmembrane conductance regulator antagonist | 0.038 0.036 DBMET01203 0.038 0.035 DBMET01204 0.05 0.009 DBMET01180 0.058 0.005 DBMET01181 | DBMET01181 | |
| 0.092 | 0.092 | 0.26 | GABA C receptor antagonist | 0.137 0.038 DBMET00069 0.142 0.035 DBMET00070 0.125 0.048 DBMET01205 0.112 0.061 DBMET01179 0.118 0.054 DBMET01206 0.26 0.005 DBMET01180 0.174 0.02 DBMET01181 | DBMET01180 | |
| 0.081 | 0.082 | 0.082 | Butyrylcholinesterase inhibitor | 0.082 0.08 DBMET01203 | DBMET01203 | |
| 0.017 | 0.021 | 0.098 | Retinoid X beta receptor agonist | 0.027 0.009 DBMET01178 0.098 0.004 DBMET01180 | DBMET01180 | |
| 0.034 | 0.039 | 0.156 | Retinoic acid alpha receptor agonist | 0.036 0.033 DBMET00069 0.156 0.003 DBMET01180 0.066 0.007 DBMET01181 | DBMET01180 | |
| 0.049 | 0.054 | 0.103 | DNA helicase inhibitor | 0.06 0.028 DBMET00069 0.054 0.038 DBMET00070 0.058 0.03 DBMET01205 0.074 0.014 DBMET01178 0.057 0.033 DBMET01179 0.057 0.034 DBMET01206 0.103 0.005 DBMET01180 0.073 0.015 DBMET01181 | DBMET01180 | |
| 0.113 | 0.119 | 0.121 | Cholinergic | 0.121 0.106 DBMET01203 0.119 0.109 DBMET01204 | DBMET01203 | |
| 0.154 | 0.161 | 0.405 | Antioxidant | 0.405 0.034 DBMET01203 0.158 0.156 DBMET00068 0.377 0.039 DBMET01204 0.355 0.045 DBMET00070 0.388 0.037 DBMET01205 0.184 0.128 DBMET01178 0.364 0.043 DBMET01206 0.232 0.094 DBMET01180 0.256 0.081 DBMET01181 | DBMET01203 | |
| 0.024 | 0.032 | 0.06 | Liver X receptor antagonist | 0.033 0.019 DBMET01180 0.06 0.008 DBMET01181 | DBMET01181 | |
| 0.076 | 0.083 | 0.106 | Estrogen-related receptor beta agonist | 0.08 0.067 DBMET01203 0.083 0.057 DBMET00068 0.083 0.057 DBMET01204 0.093 0.035 DBMET00070 0.106 0.018 DBMET01180 0.106 0.019 DBMET01181 | DBMET01181 | |
| 0.017 | 0.028 | 0.04 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.018 DBMET00070 0.037 0.005 DBMET01180 0.04 0.005 DBMET01181 | DBMET01181 | |
| 0.122 | 0.133 | 0.351 | Amyloid beta aggregation inhibitor | 0.351 0.034 DBMET01203 0.143 0.113 DBMET00068 0.332 0.039 DBMET01204 0.149 0.108 DBMET01205 0.137 0.118 DBMET01178 0.136 0.12 DBMET01206 | DBMET01203 | |
| 0.118 | 0.129 | 0.215 | Arachidonic acid antagonist | 0.137 0.104 DBMET01203 0.144 0.095 DBMET00068 0.141 0.099 DBMET01204 0.184 0.05 DBMET00070 0.147 0.091 DBMET01178 0.215 0.02 DBMET01180 0.201 0.032 DBMET01181 | DBMET01180 | |
| 0.02 | 0.032 | 0.075 | Liver X receptor beta antagonist | 0.065 0.005 DBMET01180 0.075 0.004 DBMET01181 | DBMET01181 | |
| 0.118 | 0.13 | 0.208 | Adenylate cyclase stimulant | 0.139 0.083 DBMET01203 0.129 0.103 DBMET01204 0.153 0.058 DBMET00069 0.156 0.054 DBMET00070 0.172 0.033 DBMET01205 0.125 0.112 DBMET01178 0.152 0.06 DBMET01179 0.163 0.043 DBMET01206 0.177 0.029 DBMET01180 0.208 0.01 DBMET01181 | DBMET01181 | |
| 0.044 | 0.062 | 0.062 | Nicotinic receptor alpha7 subunit antagonist | 0.062 0.027 DBMET01181 | DBMET01181 | |
| 0.013 | 0.033 | 0.035 | Geranylgeranyltransferase I inhibitor | 0.019 0.018 DBMET00069 0.019 0.017 DBMET00070 0.035 0.006 DBMET01181 | DBMET01181 | |
| 0.065 | 0.085 | 0.126 | Glycine receptor antagonist | 0.093 0.039 DBMET00070 0.126 0.015 DBMET01180 0.111 0.023 DBMET01181 | DBMET01180 | |
| 0.056 | 0.077 | 0.095 | Acetylcholine M4 receptor antagonist | 0.095 0.032 DBMET00070 | DBMET00070 | |
| 0.067 | 0.089 | 0.118 | Inducible nitric-oxide synthase inhibitor | 0.118 0.025 DBMET00069 0.105 0.033 DBMET01205 0.099 0.038 DBMET01206 0.079 0.065 DBMET01181 | DBMET00069 | |
| 0.012 | 0.035 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.01 DBMET00070 | DBMET00070 | |
| 0.029 | 0.052 | 0.124 | GABA uptake inhibitor | 0.057 0.011 DBMET00070 0.124 0.003 DBMET01180 0.097 0.004 DBMET01181 | DBMET01180 | |
| 0.039 | 0.064 | 0.082 | Bruton tyrosine kinase inhibitor | 0.082 0.019 DBMET01181 | DBMET01181 | |
| 0.222 | 0.247 | 0.55 | Apoptosis agonist | 0.45 0.091 DBMET01203 0.432 0.099 DBMET01204 0.55 0.06 DBMET00070 0.454 0.09 DBMET01205 0.434 0.098 DBMET01206 0.268 0.197 DBMET01180 0.368 0.13 DBMET01181 | DBMET00070 | |
| 0.014 | 0.04 | 0.111 | Retinoic acid beta receptor agonist | 0.111 0.003 DBMET01180 0.026 0.007 DBMET01181 | DBMET01180 | |
| 0.021 | 0.05 | 0.042 | Cholesterol ester transfer protein antagonist | 0.042 0.011 DBMET01180 0.037 0.016 DBMET01181 | DBMET01180 | |
| 0.025 | 0.056 | 0.075 | Melatonin receptor 1A agonist | 0.038 0.015 DBMET00069 0.04 0.014 DBMET00070 0.033 0.023 DBMET01179 0.041 0.013 DBMET01180 0.075 0.004 DBMET01181 | DBMET01181 | |
| 0.07 | 0.101 | 0.182 | Prolactin inhibitor | 0.103 0.053 DBMET01203 0.095 0.061 DBMET01204 0.117 0.04 DBMET00070 0.129 0.032 DBMET01180 0.182 0.012 DBMET01181 | DBMET01181 | |
| 0.14 | 0.175 | 0.262 | Spasmolytic | 0.204 0.116 DBMET01203 0.212 0.11 DBMET00068 0.198 0.122 DBMET01204 0.192 0.126 DBMET00070 0.228 0.101 DBMET01180 0.262 0.086 DBMET01181 | DBMET01181 | |
| 0.088 | 0.123 | 0.432 | Aldehyde dehydrogenase inhibitor | 0.103 0.093 DBMET00068 0.432 0.005 DBMET00070 0.103 0.093 DBMET01178 0.341 0.008 DBMET01180 0.313 0.01 DBMET01181 | DBMET00070 | |
| 0.033 | 0.069 | 0.07 | Farnesyltransferase inhibitor | 0.047 0.03 DBMET00070 0.07 0.015 DBMET01181 | DBMET01181 | |
| 0.047 | 0.084 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.056 0.034 DBMET00069 0.068 0.013 DBMET00070 0.077 0.007 DBMET01180 0.076 0.008 DBMET01181 | DBMET01180 | |
| 0.057 | 0.094 | 0.085 | Acetylcholine nicotinic antagonist | 0.075 0.06 DBMET00070 0.085 0.05 DBMET01181 | DBMET01181 | |
| 0.112 | 0.151 | 0.214 | Nitric oxide antagonist | 0.214 0.063 DBMET01203 0.199 0.068 DBMET01204 0.208 0.065 DBMET00070 0.194 0.069 DBMET01205 0.132 0.116 DBMET01178 0.182 0.075 DBMET01206 0.132 0.115 DBMET01180 0.162 0.086 DBMET01181 | DBMET01203 | |
| 0.026 | 0.065 | 0.047 | Delayed rectifier potassium channel blocker | 0.047 0.014 DBMET01181 | DBMET01181 | |
| 0.054 | 0.094 | 0.071 | Calcium channel P-type blocker | 0.061 0.053 DBMET00070 0.07 0.027 DBMET01180 0.071 0.027 DBMET01181 | DBMET01181 | |
| 0.021 | 0.063 | 0.038 | Melanocortin 1 antagonist | 0.038 0.027 DBMET00069 | DBMET00069 | |
| 0.02 | 0.062 | 0.035 | Estrogen-related receptor gamma antagonist | 0.029 0.017 DBMET01180 0.035 0.009 DBMET01181 | DBMET01181 | |
| 0.035 | 0.079 | 0.049 | Benzodiazepine antagonist | 0.049 0.028 DBMET00070 | DBMET00070 | |
| 0.014 | 0.059 | 0.027 | Follicle-stimulating hormone antagonist | 0.027 0.005 DBMET00070 0.024 0.007 DBMET01181 | DBMET00070 | |
| 0.183 | 0.229 | 0.258 | Ca(v)3.3 blocker | 0.258 0.089 DBMET00069 | DBMET00069 | |
| 0.072 | 0.12 | 0.256 | GABA C receptor rho-1 antagonist | 0.121 0.039 DBMET00069 0.136 0.028 DBMET00070 0.103 0.058 DBMET01205 0.095 0.069 DBMET01179 0.098 0.064 DBMET01206 0.256 0.004 DBMET01180 0.157 0.019 DBMET01181 | DBMET01180 | |
| 0.006 | 0.055 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.007 DBMET00070 0.015 0.007 DBMET01180 0.014 0.007 DBMET01181 | DBMET01180 | |
| 0.069 | 0.118 | 0.615 | GABA C receptor agonist | 0.109 0.058 DBMET00069 0.227 0.016 DBMET00070 0.092 0.077 DBMET01205 0.119 0.051 DBMET01178 0.087 0.083 DBMET01179 0.615 0.003 DBMET01180 0.292 0.01 DBMET01181 | DBMET01180 | |
| 0.036 | 0.085 | 0.118 | Leukotriene B4 antagonist | 0.056 0.033 DBMET01178 0.118 0.008 DBMET01180 0.075 0.017 DBMET01181 | DBMET01180 | |
| 0.028 | 0.078 | 0.089 | Nerve growth factor antagonist | 0.058 0.01 DBMET00070 0.089 0.004 DBMET01180 0.053 0.015 DBMET01181 | DBMET01180 | |
| 0.012 | 0.065 | 0.063 | Lysophosphatidic acid 1 receptor antagonist | 0.063 0.003 DBMET01180 0.021 0.014 DBMET01181 | DBMET01180 | |
| 0.017 | 0.071 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 DBMET01181 | DBMET01181 | |
| 0.035 | 0.089 | 0.066 | CXC chemokine 4 receptor antagonist | 0.066 0.038 DBMET00069 | DBMET00069 | |
| 0.02 | 0.074 | 0.032 | Hedgehog signaling activator | 0.027 0.02 DBMET00070 0.029 0.015 DBMET01180 0.032 0.009 DBMET01181 | DBMET01181 | |
| 0.037 | 0.092 | 0.054 | Acetylcholine M5 receptor antagonist | 0.054 0.051 DBMET01181 | DBMET01181 | |
| 0.075 | 0.131 | 0.113 | Phosphodiesterase 6D inhibitor | 0.107 0.041 DBMET01180 0.113 0.032 DBMET01181 | DBMET01181 | |
| 0.019 | 0.076 | 0.035 | HMG CoA reductase inhibitor | 0.031 0.03 DBMET01178 0.035 0.023 DBMET01181 | DBMET01181 | |
| 0.118 | 0.177 | 0.236 | ATPase inhibitor | 0.148 0.104 DBMET00070 0.236 0.018 DBMET01180 0.181 0.056 DBMET01181 | DBMET01180 | |
| 0.076 | 0.136 | 0.102 | Cholinergic antagonist | 0.102 0.093 DBMET01181 | DBMET01181 | |
| 0.048 | 0.108 | 0.081 | Calcium channel L-type blocker | 0.081 0.038 DBMET01180 | DBMET01180 | |
| 0.017 | 0.077 | 0.142 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET00070 0.142 0.003 DBMET01180 0.073 0.009 DBMET01181 | DBMET01180 | |
| 0.073 | 0.134 | 0.161 | Alkylator | 0.111 0.077 DBMET01203 0.1 0.088 DBMET01204 0.116 0.072 DBMET00070 0.119 0.069 DBMET01205 0.108 0.08 DBMET01206 0.139 0.052 DBMET01180 0.161 0.041 DBMET01181 | DBMET01181 | |
| 0.012 | 0.075 | 0.044 | Retinoid X beta receptor antagonist | 0.021 0.014 DBMET00070 0.044 0.003 DBMET01180 0.024 0.008 DBMET01181 | DBMET01180 | |
| 0.024 | 0.087 | 0.057 | Potassium channel Kv1.3 blocker | 0.057 0.023 DBMET00070 0.051 0.028 DBMET01181 | DBMET00070 | |
| 0.042 | 0.106 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 DBMET00070 0.084 0.047 DBMET01180 0.106 0.027 DBMET01181 | DBMET01181 | |
| 0.049 | 0.114 | 0.152 | MAO B inhibitor | 0.152 0.036 DBMET00070 0.111 0.055 DBMET01181 | DBMET00070 | |
| 0.068 | 0.133 | 0.186 | MAO inhibitor | 0.1 0.091 DBMET01203 0.111 0.08 DBMET01204 0.186 0.045 DBMET00070 0.137 0.066 DBMET01181 | DBMET00070 | |
| 0.034 | 0.1 | 0.071 | Potassium channel Kv1.5 blocker | 0.071 0.029 DBMET00069 0.06 0.037 DBMET01179 | DBMET00069 | |
| 0.053 | 0.12 | 0.105 | MAO A inhibitor | 0.093 0.069 DBMET01203 0.105 0.061 DBMET01204 0.084 0.076 DBMET00070 0.082 0.079 DBMET01181 | DBMET01204 | |
| 0.048 | 0.12 | 0.163 | Ornithine decarboxylase inhibitor | 0.124 0.023 DBMET00070 0.163 0.008 DBMET01180 0.131 0.019 DBMET01181 | DBMET01180 | |
| 0.095 | 0.169 | 0.158 | Vanilloid 1 agonist | 0.113 0.105 DBMET01203 0.136 0.056 DBMET00069 0.112 0.108 DBMET00070 0.158 0.031 DBMET01205 0.139 0.051 DBMET01179 0.154 0.034 DBMET01206 0.126 0.074 DBMET01180 0.153 0.035 DBMET01181 | DBMET01205 | |
| 0.071 | 0.146 | 0.1 | Acetylcholine antagonist | 0.1 0.093 DBMET01181 | DBMET01181 | |
| 0.158 | 0.233 | 0.366 | Tyrosine 3 hydroxylase inhibitor | 0.22 0.103 DBMET01203 0.218 0.107 DBMET01204 0.193 0.148 DBMET00069 0.31 0.029 DBMET00070 0.264 0.056 DBMET01205 0.185 0.164 DBMET01178 0.261 0.058 DBMET01206 0.366 0.013 DBMET01180 0.348 0.016 DBMET01181 | DBMET01180 | |
| 0.035 | 0.113 | 0.101 | Nicotinic alpha3beta2 receptor antagonist | 0.06 0.026 DBMET00070 0.101 0.007 DBMET01180 0.08 0.013 DBMET01181 | DBMET01180 | |
| 0.012 | 0.09 | 0.119 | Retinoid X receptor agonist | 0.032 0.027 DBMET00070 0.119 0.004 DBMET01180 0.066 0.012 DBMET01181 | DBMET01180 | |
| 0.011 | 0.09 | 0.125 | Retinoic acid receptor agonist | 0.125 0.004 DBMET01180 0.023 0.017 DBMET01181 | DBMET01180 | |
| 0.007 | 0.088 | 0.029 | Follicle-stimulating hormone agonist | 0.029 0.01 DBMET00070 | DBMET00070 | |
| 0.118 | 0.201 | 0.202 | Ca2+-transporting ATPase inhibitor | 0.165 0.018 DBMET00070 0.202 0.003 DBMET01180 0.18 0.007 DBMET01181 | DBMET01180 | |
| 0.024 | 0.109 | 0.04 | Plasmepsin II inhibitor | 0.04 0.03 DBMET01181 | DBMET01181 | |
| 0.062 | 0.146 | 0.179 | Chelator | 0.179 0.028 DBMET01203 0.165 0.031 DBMET01204 0.144 0.038 DBMET01205 0.095 0.084 DBMET01178 0.137 0.041 DBMET01206 0.124 0.05 DBMET01180 | DBMET01203 | |
| 0.061 | 0.146 | 0.14 | Anesthetic local | 0.138 0.055 DBMET01180 0.14 0.054 DBMET01181 | DBMET01181 | |
| 0.003 | 0.09 | 0.019 | Lysophosphatidic acid receptor 3 agonist | 0.019 0.005 DBMET01180 0.018 0.006 DBMET01181 | DBMET01180 | |
| 0.061 | 0.15 | 0.15 | Anabolic | 0.144 0.021 DBMET00070 0.15 0.018 DBMET01180 0.138 0.025 DBMET01181 | DBMET01180 | |
| 0.012 | 0.103 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 DBMET00070 0.039 0.006 DBMET01180 0.032 0.01 DBMET01181 | DBMET01180 | |
| 0.011 | 0.102 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET01180 0.02 0.01 DBMET01181 | DBMET01180 | |
| 0.009 | 0.101 | 0.076 | Leukotriene B4 receptor 2 antagonist | 0.076 0.004 DBMET01180 0.029 0.009 DBMET01181 | DBMET01180 | |
| 0.037 | 0.129 | 0.144 | Elastase 1 inhibitor | 0.144 0.007 DBMET00070 0.064 0.055 DBMET01206 0.085 0.031 DBMET01180 0.081 0.034 DBMET01181 | DBMET00070 | |
| 0.019 | 0.112 | 0.063 | Retinoid X alpha receptor antagonist | 0.032 0.028 DBMET00070 0.063 0.004 DBMET01180 0.042 0.013 DBMET01181 | DBMET01180 | |
| 0.089 | 0.183 | 0.191 | Sigma receptor agonist | 0.191 0.065 DBMET01180 | DBMET01180 | |
| 0.013 | 0.109 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 DBMET01180 0.031 0.009 DBMET01181 | DBMET01180 | |
| 0.158 | 0.256 | 0.324 | Apoptosis antagonist | 0.242 0.136 DBMET01203 0.231 0.147 DBMET01204 0.311 0.078 DBMET00070 0.25 0.128 DBMET01205 0.224 0.153 DBMET01178 0.239 0.138 DBMET01206 0.315 0.076 DBMET01180 0.324 0.07 DBMET01181 | DBMET01181 | |
| 0.045 | 0.144 | 0.161 | Histamine N-methyltransferase inhibitor | 0.096 0.049 DBMET00070 0.161 0.011 DBMET01180 0.102 0.044 DBMET01181 | DBMET01180 | |
| 0.021 | 0.12 | 0.073 | Retinoid X receptor antagonist | 0.036 0.03 DBMET00070 0.073 0.004 DBMET01180 0.048 0.014 DBMET01181 | DBMET01180 | |
| 0.107 | 0.207 | 0.155 | CC chemokine 6 receptor antagonist | 0.155 0.016 DBMET01180 0.12 0.115 DBMET01181 | DBMET01180 | |
| 0.016 | 0.115 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.048 0.01 DBMET01180 0.043 0.014 DBMET01181 | DBMET01180 | |
| 0.023 | 0.123 | 0.053 | Cannabinoid CB1 receptor agonist | 0.053 0.05 DBMET01181 | DBMET01181 | |
| 0.052 | 0.152 | 0.293 | HIV-1 integrase (Overall Integration) inhibitor | 0.167 0.02 DBMET00070 0.09 0.065 DBMET01205 0.09 0.065 DBMET01206 0.284 0.004 DBMET01180 0.293 0.004 DBMET01181 | DBMET01181 | |
| 0.005 | 0.106 | 0.011 | Melatonin 2 antagonist | 0.011 0.01 DBMET01181 | DBMET01181 | |
| 0.06 | 0.162 | 0.191 | Adenylate cyclase inhibitor | 0.155 0.042 DBMET00070 0.175 0.032 DBMET01180 0.191 0.027 DBMET01181 | DBMET01181 | |
| 0.016 | 0.122 | 0.031 | Dipeptidyl peptidase II inhibitor | 0.031 0.024 DBMET01180 | DBMET01180 | |
| 0.017 | 0.123 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 DBMET01180 0.034 0.008 DBMET01181 | DBMET01181 | |
| 0.029 | 0.138 | 0.077 | Neuronal nicotinic receptor antagonist | 0.077 0.039 DBMET01181 | DBMET01181 | |
| 0.014 | 0.125 | 0.103 | Peroxisome proliferator-activated receptor alpha agonist | 0.043 0.038 DBMET01178 0.103 0.012 DBMET01180 | DBMET01180 | |
| 0.037 | 0.149 | 0.104 | Phospholipase D inhibitor | 0.086 0.026 DBMET00070 0.104 0.012 DBMET01180 0.093 0.02 DBMET01181 | DBMET01180 | |
| 0.054 | 0.166 | 0.477 | Ferrochelatase inhibitor | 0.241 0.014 DBMET00070 0.477 0.003 DBMET01180 0.274 0.01 DBMET01181 | DBMET01180 | |
| 0.022 | 0.136 | 0.056 | Thymidine kinase inhibitor | 0.037 0.035 DBMET01180 0.056 0.015 DBMET01181 | DBMET01181 | |
| 0.057 | 0.172 | 0.151 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.035 DBMET00070 0.126 0.025 DBMET01180 0.151 0.011 DBMET01181 | DBMET01181 | |
| 0.015 | 0.131 | 0.095 | Angiotensin II receptor antagonist | 0.051 0.006 DBMET00070 0.095 0.003 DBMET01180 0.064 0.004 DBMET01181 | DBMET01180 | |
| 0.049 | 0.165 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.064 DBMET01180 | DBMET01180 | |
| 0.058 | 0.173 | 0.157 | ABCA1 expression enhancer | 0.1 0.05 DBMET01178 0.157 0.016 DBMET01180 0.087 0.072 DBMET01181 | DBMET01180 | |
| 0.079 | 0.195 | 0.204 | Neurotrophic factor | 0.204 0.026 DBMET00070 0.172 0.043 DBMET01180 | DBMET00070 | |
| 0.019 | 0.137 | 0.062 | Tryptophan 5 hydroxylase inhibitor | 0.04 0.015 DBMET00070 0.062 0.004 DBMET01180 0.044 0.01 DBMET01181 | DBMET01180 | |
| 0.017 | 0.138 | 0.075 | Thymidylate synthase inhibitor | 0.042 0.038 DBMET00070 0.064 0.014 DBMET01180 0.075 0.009 DBMET01181 | DBMET01181 | |
| 0.084 | 0.208 | 0.144 | Cyclin-dependent kinase 8 inhibitor | 0.143 0.086 DBMET01180 0.144 0.085 DBMET01181 | DBMET01181 | |
| 0.029 | 0.154 | 0.083 | Bombesin 3 receptor antagonist | 0.083 0.018 DBMET01180 | DBMET01180 | |
| 0.137 | 0.262 | 0.234 | Neuropeptide Y2 antagonist | 0.189 0.14 DBMET00070 0.234 0.073 DBMET01180 0.203 0.114 DBMET01181 | DBMET01180 | |
| 0.049 | 0.175 | 0.158 | Estrogen receptor alpha antagonist | 0.158 0.011 DBMET00070 0.084 0.043 DBMET01180 0.104 0.025 DBMET01181 | DBMET00070 | |
| 0.032 | 0.158 | 0.236 | Factor III inhibitor | 0.047 0.042 DBMET00070 0.049 0.038 DBMET01205 0.05 0.035 DBMET01206 0.236 0.002 DBMET01180 0.081 0.007 DBMET01181 | DBMET01180 | |
| 0.075 | 0.2 | 0.127 | Acetylcholine M1 receptor antagonist | 0.125 0.102 DBMET01180 0.127 0.1 DBMET01181 | DBMET01181 | |
| 0.022 | 0.148 | 0.046 | Histamine H1 receptor agonist | 0.046 0.026 DBMET00070 | DBMET00070 | |
| 0.01 | 0.137 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.018 DBMET01180 0.025 0.007 DBMET01181 | DBMET01181 | |
| 0.012 | 0.14 | 0.092 | Estradiol 17 beta-dehydrogenase inhibitor | 0.092 0.011 DBMET00070 0.057 0.021 DBMET01180 0.071 0.015 DBMET01181 | DBMET00070 | |
| 0.129 | 0.257 | 0.327 | Gastrin inhibitor | 0.222 0.116 DBMET00070 0.327 0.018 DBMET01180 0.283 0.046 DBMET01181 | DBMET01180 | |
| 0.035 | 0.164 | 0.104 | Protease 3C (Human rhinovirus) inhibitor | 0.104 0.014 DBMET00070 0.071 0.036 DBMET01180 0.078 0.029 DBMET01181 | DBMET00070 | |
| 0.034 | 0.164 | 0.104 | Pregnane X receptor antagonist | 0.104 0.003 DBMET00070 0.085 0.005 DBMET01180 0.064 0.022 DBMET01181 | DBMET00070 | |
| 0.114 | 0.244 | 0.189 | Heat shock protein 70 antagonist | 0.142 0.067 DBMET00070 0.189 0.009 DBMET01180 0.158 0.031 DBMET01181 | DBMET01180 | |
| 0.152 | 0.284 | 0.468 | 5 Hydroxytryptamine uptake stimulant | 0.333 0.031 DBMET00070 0.468 0.005 DBMET01180 0.413 0.012 DBMET01181 | DBMET01180 | |
| 0.12 | 0.252 | 0.541 | 5 Hydroxytryptamine release stimulant | 0.328 0.062 DBMET00070 0.363 0.054 DBMET01180 0.541 0.021 DBMET01181 | DBMET01181 | |
| 0.031 | 0.164 | 0.094 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.048 DBMET00070 0.068 0.02 DBMET01180 0.094 0.01 DBMET01181 | DBMET01181 | |
| 0.073 | 0.206 | 0.276 | Protein kinase stimulant | 0.203 0.04 DBMET00070 0.221 0.035 DBMET01180 0.276 0.02 DBMET01181 | DBMET01181 | |
| 0.022 | 0.155 | 0.087 | 5 Hydroxytryptamine 1D antagonist | 0.087 0.028 DBMET00070 | DBMET00070 | |
| 0.067 | 0.2 | 0.166 | Nav1.2 sodium channel blocker | 0.139 0.065 DBMET01180 0.166 0.049 DBMET01181 | DBMET01181 | |
| 0.047 | 0.182 | 0.096 | Gastric antisecretory | 0.095 0.072 DBMET01180 0.096 0.071 DBMET01181 | DBMET01181 | |
| 0.017 | 0.151 | 0.054 | Membrane dipeptidase inhibitor | 0.054 0.013 DBMET01180 0.039 0.028 DBMET01181 | DBMET01180 | |
| 0.013 | 0.148 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 DBMET01180 0.058 0.015 DBMET01181 | DBMET01180 | |
| 0.155 | 0.291 | 0.409 | Antibacterial | 0.281 0.15 DBMET01203 0.263 0.165 DBMET01204 0.33 0.114 DBMET00070 0.345 0.105 DBMET01205 0.229 0.197 DBMET01179 0.328 0.116 DBMET01206 0.409 0.073 DBMET01180 0.31 0.128 DBMET01181 | DBMET01180 | |
| 0.06 | 0.197 | 0.751 | Alpha-N-acetylglucosaminidase inhibitor | 0.411 0.008 DBMET00070 0.14 0.061 DBMET01179 0.751 0.003 DBMET01180 0.637 0.004 DBMET01181 | DBMET01180 | |
| 0.009 | 0.146 | 0.033 | Neuraminidase (Influenza B) inhibitor | 0.033 0.004 DBMET01180 0.021 0.015 DBMET01181 | DBMET01180 | |
| 0.03 | 0.171 | 0.063 | Vanilloid 2 antagonist | 0.052 0.037 DBMET01203 0.048 0.046 DBMET01204 0.063 0.019 DBMET01205 0.059 0.024 DBMET01206 | DBMET01205 | |
| 0.006 | 0.147 | 0.048 | Progesterone antagonist | 0.048 0.019 DBMET00070 0.031 0.028 DBMET01181 | DBMET00070 | |
| 0.009 | 0.15 | 0.056 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.056 0.009 DBMET00070 0.038 0.017 DBMET01180 0.052 0.01 DBMET01181 | DBMET00070 | |
| 0.014 | 0.155 | 0.054 | Oleamide hydrolase inhibitor | 0.05 0.028 DBMET00070 0.054 0.024 DBMET01180 | DBMET01180 | |
| 0.003 | 0.145 | 0.02 | Adenosine A2a receptor agonist | 0.02 0.008 DBMET01181 | DBMET01181 | |
| 0.006 | 0.148 | 0.075 | Methionyl aminopeptidase 2 inhibitor | 0.024 0.019 DBMET00070 0.075 0.004 DBMET01180 0.028 0.015 DBMET01181 | DBMET01180 | |
| 0.065 | 0.208 | 0.189 | Cathepsin H inhibitor | 0.15 0.046 DBMET00070 0.189 0.026 DBMET01180 0.158 0.041 DBMET01181 | DBMET01180 | |
| 0.01 | 0.153 | 0.049 | Retinoic acid gamma receptor agonist | 0.049 0.004 DBMET01180 | DBMET01180 | |
| 0.009 | 0.153 | 0.063 | Phosphoglycerate kinase inhibitor | 0.048 0.014 DBMET01180 0.063 0.011 DBMET01181 | DBMET01181 | |
| 0.036 | 0.181 | 0.19 | GABA aminotransferase inhibitor | 0.162 0.006 DBMET00070 0.19 0.005 DBMET01180 0.103 0.025 DBMET01181 | DBMET01180 | |
| 0.082 | 0.23 | 0.223 | HERG channel blocker | 0.223 0.078 DBMET00068 | DBMET00068 | |
| 0.09 | 0.239 | 0.183 | Antiamyloidogenic | 0.183 0.112 DBMET01203 0.166 0.127 DBMET01204 0.172 0.121 DBMET00070 0.181 0.114 DBMET01180 0.169 0.124 DBMET01181 | DBMET01203 | |
| 0.047 | 0.195 | 0.105 | Vanilloid 4 agonist | 0.079 0.043 DBMET00070 0.079 0.043 DBMET01180 0.105 0.013 DBMET01181 | DBMET01181 | |
| 0.097 | 0.247 | 0.385 | Neurotrophic factor enhancer | 0.338 0.011 DBMET00070 0.148 0.142 DBMET01205 0.273 0.027 DBMET01180 0.385 0.006 DBMET01181 | DBMET01181 | |
| 0.023 | 0.173 | 0.133 | Leukotriene antagonist | 0.133 0.013 DBMET01180 0.089 0.027 DBMET01181 | DBMET01180 | |
| 0.047 | 0.2 | 0.208 | Cholesterol synthesis inhibitor | 0.102 0.085 DBMET00070 0.208 0.025 DBMET01180 0.145 0.047 DBMET01181 | DBMET01180 | |
| 0.096 | 0.249 | 0.259 | Lipocortins synthesis antagonist | 0.152 0.102 DBMET01178 0.259 0.031 DBMET01180 | DBMET01180 | |
| 0.028 | 0.182 | 0.055 | 5 Hydroxytryptamine 7 agonist | 0.055 0.042 DBMET00070 | DBMET00070 | |
| 0.011 | 0.165 | 0.029 | Purinergic P2Y15 antagonist | 0.028 0.021 DBMET00070 0.029 0.02 DBMET01180 0.029 0.018 DBMET01181 | DBMET01181 | |
| 0.007 | 0.161 | 0.032 | Imidazoline I1 receptor antagonist | 0.025 0.009 DBMET00070 0.032 0.006 DBMET01181 | DBMET01181 | |
| 0.063 | 0.217 | 0.225 | TRPA1 agonist | 0.225 0.007 DBMET00070 0.219 0.008 DBMET01180 0.122 0.056 DBMET01181 | DBMET00070 | |
| 0.007 | 0.163 | 0.038 | Dopamine D1 agonist | 0.037 0.006 DBMET01203 0.034 0.007 DBMET01204 0.038 0.006 DBMET01205 0.035 0.007 DBMET01206 | DBMET01205 | |
| 0.005 | 0.162 | 0.021 | Telomerase stimulant | 0.017 0.013 DBMET01180 0.021 0.006 DBMET01181 | DBMET01181 | |
| 0.021 | 0.178 | 0.055 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET00070 0.05 0.03 DBMET01181 | DBMET00070 | |
| 0.062 | 0.219 | 0.116 | CDC-like kinase 3 inhibitor | 0.116 0.048 DBMET00070 | DBMET00070 | |
| 0.02 | 0.178 | 0.166 | Peroxisome proliferator-activated receptor gamma agonist | 0.079 0.042 DBMET01178 0.166 0.01 DBMET01180 | DBMET01180 | |
| 0.001 | 0.159 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET00070 | DBMET00070 | |
| 0.02 | 0.179 | 0.072 | 5 Hydroxytryptamine 1B antagonist | 0.072 0.039 DBMET00070 | DBMET00070 | |
| 0.009 | 0.169 | 0.023 | Caspase 8 inhibitor | 0.023 0.009 DBMET01180 0.018 0.017 DBMET01181 | DBMET01180 | |
| 0.036 | 0.196 | 0.114 | Somatostatin 1 agonist | 0.097 0.036 DBMET01180 0.114 0.026 DBMET01181 | DBMET01181 | |
| 0.006 | 0.167 | 0.059 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.059 0.005 DBMET00070 0.025 0.014 DBMET01181 | DBMET00070 | |
| 0.018 | 0.181 | 0.073 | Prolyl endopeptidase inhibitor | 0.073 0.014 DBMET00070 0.059 0.025 DBMET01180 0.048 0.039 DBMET01181 | DBMET00070 | |
| 0.01 | 0.176 | 0.052 | Ribonucleoside-diphosphate reductase inhibitor | 0.052 0.039 DBMET01181 | DBMET01181 | |
| 0.013 | 0.182 | 0.096 | NMDA 2C receptor antagonist | 0.096 0.017 DBMET01180 | DBMET01180 | |
| 0.03 | 0.199 | 0.1 | Potassium channel intermediate-conductance Ca-activated blocker | 0.08 0.017 DBMET00070 0.096 0.01 DBMET01180 0.1 0.009 DBMET01181 | DBMET01181 | |
| 0.007 | 0.177 | 0.022 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET01180 0.022 0.008 DBMET01181 | DBMET01181 | |
| 0.008 | 0.178 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.008 DBMET01180 | DBMET01180 | |
| 0.012 | 0.183 | 0.059 | Dopamine D5 agonist | 0.052 0.016 DBMET00070 0.04 0.028 DBMET01205 0.037 0.032 DBMET01206 0.059 0.012 DBMET01180 0.059 0.012 DBMET01181 | DBMET01181 | |
| 0.018 | 0.189 | 0.09 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.038 DBMET00070 0.09 0.006 DBMET01180 0.071 0.014 DBMET01181 | DBMET01180 | |
| 0.009 | 0.182 | 0.053 | Ribonucleotide reductase inhibitor | 0.053 0.04 DBMET01181 | DBMET01181 | |
| 0.01 | 0.183 | 0.05 | Melatonin 2 agonist | 0.05 0.01 DBMET00070 0.04 0.016 DBMET01181 | DBMET00070 | |
| 0.011 | 0.184 | 0.059 | Alpha 1d adrenoreceptor agonist | 0.059 0.011 DBMET00070 0.044 0.022 DBMET01180 0.046 0.02 DBMET01181 | DBMET00070 | |
| 0.021 | 0.195 | 0.047 | Vanilloid 3 antagonist | 0.039 0.024 DBMET00070 0.042 0.018 DBMET01180 0.047 0.012 DBMET01181 | DBMET01181 | |
| 0.058 | 0.233 | 0.248 | Photosensitizer | 0.142 0.036 DBMET00070 0.199 0.013 DBMET01180 0.248 0.006 DBMET01181 | DBMET01181 | |
| 0.048 | 0.223 | 0.121 | DNA polymerase I inhibitor | 0.105 0.081 DBMET01203 0.096 0.091 DBMET01204 0.121 0.067 DBMET01180 0.101 0.085 DBMET01181 | DBMET01180 | |
| 0.004 | 0.179 | 0.059 | Arginase inhibitor | 0.059 0.011 DBMET01180 0.038 0.024 DBMET01181 | DBMET01180 | |
| 0.008 | 0.184 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET01180 | DBMET01180 | |
| 0.054 | 0.23 | 0.407 | Carbonic anhydrase XV inhibitor | 0.129 0.041 DBMET00070 0.407 0.004 DBMET01180 0.332 0.006 DBMET01181 | DBMET01180 | |
| 0.003 | 0.18 | 0.03 | Human herpes virus 5 capsid protein P40 inhibitor | 0.024 0.004 DBMET01180 0.03 0.004 DBMET01181 | DBMET01181 | |
| 0.028 | 0.205 | 0.158 | NMDA receptor agonist | 0.158 0.007 DBMET01180 0.071 0.035 DBMET01181 | DBMET01180 | |
| 0.021 | 0.198 | 0.357 | Aconitate hydratase inhibitor | 0.098 0.009 DBMET00070 0.357 0.002 DBMET01180 0.132 0.005 DBMET01181 | DBMET01180 | |
| 0.058 | 0.236 | 0.25 | Toll-Like receptor 2 antagonist | 0.25 0.009 DBMET00070 0.117 0.081 DBMET01205 0.109 0.091 DBMET01206 0.194 0.027 DBMET01180 0.228 0.014 DBMET01181 | DBMET00070 | |
| 0.074 | 0.253 | 0.283 | Insulin sensitizer | 0.212 0.061 DBMET00070 0.283 0.02 DBMET01180 0.231 0.046 DBMET01181 | DBMET01180 | |
| 0.008 | 0.188 | 0.125 | Fumarate hydratase inhibitor | 0.036 0.022 DBMET00070 0.125 0.004 DBMET01180 0.062 0.01 DBMET01181 | DBMET01180 | |
| 0.037 | 0.217 | 0.088 | Exportin-1 inhibitor | 0.088 0.016 DBMET00070 0.082 0.023 DBMET01180 0.08 0.025 DBMET01181 | DBMET00070 | |
| 0.005 | 0.185 | 0.07 | Leukotriene B4 receptor 1 antagonist | 0.07 0.004 DBMET01180 0.036 0.014 DBMET01181 | DBMET01180 | |
| 0.101 | 0.282 | 0.197 | Neurotensin receptor agonist | 0.152 0.096 DBMET00070 0.197 0.036 DBMET01180 0.174 0.056 DBMET01181 | DBMET01180 | |
| 0.019 | 0.2 | 0.059 | Alpha 2 adrenoreceptor agonist | 0.054 0.051 DBMET00070 0.059 0.044 DBMET01181 | DBMET01181 | |
| 0.006 | 0.188 | 0.108 | Bombesin 3 receptor agonist | 0.108 0.003 DBMET01180 | DBMET01180 | |
| 0.014 | 0.196 | 0.073 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 DBMET01180 0.073 0.003 DBMET01181 | DBMET01181 | |
| 0.021 | 0.204 | 0.075 | Kainate receptor agonist | 0.044 0.023 DBMET00070 0.075 0.004 DBMET01180 0.051 0.013 DBMET01181 | DBMET01180 | |
| 0.022 | 0.206 | 0.058 | Dopamine beta hydroxylase inhibitor | 0.049 0.034 DBMET00070 0.058 0.017 DBMET01180 0.058 0.017 DBMET01181 | DBMET01181 | |
| 0.009 | 0.193 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.011 DBMET01180 | DBMET01180 | |
| 0.006 | 0.19 | 0.068 | Glucagon receptor antagonist | 0.068 0.006 DBMET01181 | DBMET01181 | |
| 0.027 | 0.212 | 0.195 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.191 0.01 DBMET00070 0.171 0.014 DBMET01180 0.195 0.01 DBMET01181 | DBMET01181 | |
| 0.004 | 0.189 | 0.028 | Alpha 2c adrenoreceptor agonist | 0.028 0.005 DBMET00070 0.018 0.013 DBMET01181 | DBMET00070 | |
| 0.007 | 0.192 | 0.079 | AMPA 3 receptor antagonist | 0.031 0.02 DBMET00070 0.079 0.004 DBMET01180 | DBMET01180 | |
| 0.02 | 0.205 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 DBMET01181 | DBMET01181 | |
| 0.004 | 0.19 | 0.052 | Prostaglandin EP2 agonist | 0.052 0.005 DBMET01180 0.042 0.008 DBMET01181 | DBMET01180 | |
| 0.016 | 0.203 | 0.77 | Alcohol oxidase inhibitor | 0.153 0.01 DBMET00070 0.77 0.003 DBMET01180 0.189 0.007 DBMET01181 | DBMET01180 | |
| 0.016 | 0.203 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 DBMET01180 | DBMET01180 | |
| 0.007 | 0.195 | 0.135 | TRPM8 blocker | 0.044 0.02 DBMET00070 0.135 0.005 DBMET01180 0.05 0.016 DBMET01181 | DBMET01180 | |
| 0.027 | 0.215 | 0.169 | Aminopeptidase I inhibitor | 0.09 0.034 DBMET00070 0.169 0.01 DBMET01180 0.113 0.022 DBMET01181 | DBMET01180 | |
| 0.038 | 0.226 | 0.069 | Heme oxygenase stimulant | 0.069 0.026 DBMET01180 | DBMET01180 | |
| 0.021 | 0.211 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.072 0.012 DBMET00070 0.084 0.008 DBMET01180 0.104 0.004 DBMET01181 | DBMET01181 | |
| 0.01 | 0.202 | 0.045 | Lysophosphatidic acid 2 receptor antagonist | 0.045 0.01 DBMET01180 0.032 0.019 DBMET01181 | DBMET01180 | |
| 0.021 | 0.213 | 0.09 | Androgen agonist | 0.07 0.03 DBMET01180 0.09 0.019 DBMET01181 | DBMET01181 | |
| 0.01 | 0.202 | 0.027 | Acid ceramidase inhibitor | 0.027 0.015 DBMET01181 | DBMET01181 | |
| 0.011 | 0.203 | 0.091 | NMDA 2A receptor antagonist | 0.091 0.016 DBMET01180 | DBMET01180 | |
| 0.014 | 0.207 | 0.082 | Sphingosine 1-phosphate receptor agonist | 0.075 0.01 DBMET01180 0.082 0.008 DBMET01181 | DBMET01181 | |
| 0.036 | 0.23 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.065 0.036 DBMET01181 | DBMET01181 | |
| 0.022 | 0.215 | 0.075 | Histamine H1 receptor antagonist | 0.075 0.063 DBMET01180 | DBMET01180 | |
| 0.087 | 0.281 | 0.43 | Succinate dehydrogenase inhibitor | 0.259 0.019 DBMET00070 0.142 0.128 DBMET01179 0.43 0.004 DBMET01180 0.283 0.014 DBMET01181 | DBMET01180 | |
| 0.003 | 0.197 | 0.054 | Prostaglandin H2 antagonist | 0.054 0.003 DBMET01180 0.027 0.016 DBMET01181 | DBMET01180 | |
| 0.033 | 0.229 | 0.269 | Glutamate dehydrogenase inhibitor | 0.19 0.011 DBMET00070 0.269 0.006 DBMET01180 0.144 0.017 DBMET01181 | DBMET01180 | |
| 0.004 | 0.201 | 0.072 | Retinoic acid receptor gamma antagonist | 0.072 0.003 DBMET01180 | DBMET01180 | |
| 0.015 | 0.212 | 0.064 | Fibroblast growth factor 4 antagonist | 0.064 0.033 DBMET00070 | DBMET00070 | |
| 0.007 | 0.204 | 0.043 | Peroxisome proliferator-activated receptor delta agonist | 0.043 0.015 DBMET01180 0.034 0.022 DBMET01181 | DBMET01180 | |
| 0.007 | 0.205 | 0.072 | Prostaglandin EP4 antagonist | 0.072 0.005 DBMET01180 0.06 0.007 DBMET01181 | DBMET01180 | |
| 0.007 | 0.204 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.041 0.011 DBMET00070 0.037 0.015 DBMET01180 | DBMET00070 | |
| 0.019 | 0.218 | 0.147 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.147 0.007 DBMET01180 0.08 0.024 DBMET01181 | DBMET01180 | |
| 0.015 | 0.214 | 0.077 | Liver X receptor alpha agonist | 0.062 0.011 DBMET01180 0.077 0.007 DBMET01181 | DBMET01181 | |
| 0.003 | 0.202 | 0.081 | Retinoic acid beta receptor antagonist | 0.081 0.003 DBMET01180 | DBMET01180 | |
| 0.004 | 0.204 | 0.019 | Adenosine A2 receptor agonist | 0.019 0.008 DBMET01181 | DBMET01181 | |
| 0.006 | 0.207 | 0.128 | Bombesin agonist | 0.128 0.003 DBMET01180 | DBMET01180 | |
| 0.007 | 0.209 | 0.063 | Nicotinic acid receptor 2 antagonist | 0.025 0.022 DBMET00070 0.063 0.003 DBMET01180 0.034 0.009 DBMET01181 | DBMET01180 | |
| 0.006 | 0.208 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00070 0.015 0.012 DBMET01181 | DBMET00070 | |
| 0.002 | 0.206 | 0.019 | Aminopeptidase A inhibitor | 0.019 0.012 DBMET01180 | DBMET01180 | |
| 0.039 | 0.243 | 0.383 | UDP-glucose 4-epimerase inhibitor | 0.202 0.018 DBMET00070 0.383 0.006 DBMET01180 0.353 0.008 DBMET01181 | DBMET01180 | |
| 0.002 | 0.207 | 0.012 | Imidazoline I2 receptor antagonist | 0.012 0.006 DBMET01181 | DBMET01181 | |
| 0.008 | 0.213 | 0.059 | Liver X receptor beta agonist | 0.035 0.02 DBMET01180 0.059 0.008 DBMET01181 | DBMET01181 | |
| 0.035 | 0.241 | 0.163 | Glycine receptor agonist | 0.08 0.038 DBMET00070 0.163 0.005 DBMET01180 0.097 0.023 DBMET01181 | DBMET01180 | |
| 0.017 | 0.224 | 0.089 | Alpha-mannosidase inhibitor | 0.052 0.039 DBMET00070 0.049 0.045 DBMET01179 0.065 0.021 DBMET01180 0.089 0.008 DBMET01181 | DBMET01181 | |
| 0.01 | 0.218 | 0.079 | Angiotensin AT1 receptor antagonist | 0.06 0.006 DBMET00070 0.079 0.003 DBMET01180 0.065 0.004 DBMET01181 | DBMET01180 | |
| 0.002 | 0.21 | 0.046 | Peroxisome proliferator-activated receptor alpha antagonist | 0.021 0.015 DBMET00070 0.046 0.009 DBMET01180 | DBMET01180 | |
| 0.007 | 0.215 | 0.059 | Antimetabolite | 0.059 0.026 DBMET01181 | DBMET01181 | |
| 0.033 | 0.242 | 0.153 | Falcipain 3 inhibitor | 0.109 0.062 DBMET00070 0.153 0.035 DBMET01180 0.116 0.057 DBMET01181 | DBMET01180 | |
| 0.056 | 0.265 | 0.123 | Acetylcholine release stimulant | 0.106 0.074 DBMET00070 0.113 0.061 DBMET01180 0.123 0.044 DBMET01181 | DBMET01181 | |
| 0.023 | 0.233 | 0.087 | Botulinum neurotoxin type A inhibitor | 0.087 0.014 DBMET00070 | DBMET00070 | |
| 0.034 | 0.245 | 0.079 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET01205 0.061 0.046 DBMET01179 0.062 0.041 DBMET01206 0.062 0.041 DBMET01180 0.079 0.01 DBMET01181 | DBMET01181 | |
| 0.022 | 0.233 | 0.275 | Glutamate decarboxylase inhibitor | 0.113 0.023 DBMET00070 0.275 0.004 DBMET01180 0.127 0.019 DBMET01181 | DBMET01180 | |
| 0.048 | 0.26 | 0.251 | Psychostimulant | 0.235 0.064 DBMET00070 0.199 0.08 DBMET01180 0.251 0.058 DBMET01181 | DBMET01181 | |
| 0.016 | 0.229 | 0.226 | Phosphofructokinase-1 inhibitor | 0.206 0.01 DBMET00070 0.226 0.009 DBMET01180 0.196 0.011 DBMET01181 | DBMET01180 | |
| 0.004 | 0.218 | 0.043 | Free fatty acid receptor 1 agonist | 0.017 0.013 DBMET01180 0.043 0.005 DBMET01181 | DBMET01181 | |
| 0.002 | 0.216 | 0.011 | Thromboxane agonist | 0.011 0.007 DBMET01180 0.011 0.007 DBMET01181 | DBMET01181 | |
| 0.004 | 0.219 | 0.08 | Retinoic acid alpha receptor antagonist | 0.08 0.003 DBMET01180 0.02 0.014 DBMET01181 | DBMET01180 | |
| 0.007 | 0.222 | 0.064 | Sphingosine 1-phosphate receptor 1 agonist | 0.057 0.014 DBMET01180 0.064 0.011 DBMET01181 | DBMET01181 | |
| 0.018 | 0.234 | 0.176 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.09 0.017 DBMET00070 0.1 0.014 DBMET01180 0.176 0.007 DBMET01181 | DBMET01181 | |
| 0.054 | 0.27 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 DBMET00070 0.082 0.057 DBMET01180 0.087 0.044 DBMET01181 | DBMET01181 | |
| 0.002 | 0.218 | 0.04 | Angiotensin AT1B receptor antagonist | 0.015 0.009 DBMET00070 0.04 0.003 DBMET01180 0.024 0.005 DBMET01181 | DBMET01180 | |
| 0.019 | 0.236 | 0.151 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.151 0.005 DBMET00070 0.11 0.009 DBMET01180 0.106 0.009 DBMET01181 | DBMET00070 | |
| 0.035 | 0.252 | 0.07 | Phosphodiesterase VI inhibitor | 0.07 0.063 DBMET01181 | DBMET01181 | |
| 0.004 | 0.222 | 0.022 | Adenosine kinase inhibitor | 0.022 0.014 DBMET01181 | DBMET01181 | |
| 0.003 | 0.222 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 DBMET00070 0.036 0.014 DBMET01180 0.042 0.011 DBMET01181 | DBMET01181 | |
| 0.02 | 0.239 | 0.566 | Porphobilinogen synthase inhibitor | 0.474 0.004 DBMET00070 0.566 0.003 DBMET01180 0.44 0.004 DBMET01181 | DBMET01180 | |
| 0.02 | 0.24 | 0.089 | Thromboxane synthase inhibitor | 0.089 0.009 DBMET01180 0.057 0.032 DBMET01181 | DBMET01180 | |
| 0.042 | 0.262 | 0.195 | Nav1.6 sodium channel blocker | 0.123 0.091 DBMET00070 0.119 0.098 DBMET01180 0.195 0.021 DBMET01181 | DBMET01181 | |
| 0.004 | 0.224 | 0.04 | Alpha 2a adrenoreceptor agonist | 0.04 0.004 DBMET00070 | DBMET00070 | |
| 0.003 | 0.224 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET01181 | DBMET01181 | |
| 0.024 | 0.246 | 0.044 | Bombesin 2 receptor antagonist | 0.044 0.043 DBMET01180 | DBMET01180 | |
| 0.005 | 0.228 | 0.077 | Retinoic acid receptor antagonist | 0.077 0.003 DBMET01180 | DBMET01180 | |
| 0.012 | 0.236 | 0.046 | Complement factor 1s inhibitor | 0.046 0.003 DBMET00070 0.035 0.005 DBMET01180 0.04 0.004 DBMET01181 | DBMET00070 | |
| 0.025 | 0.249 | 0.13 | Cathepsin G inhibitor | 0.066 0.059 DBMET00070 0.118 0.028 DBMET01180 0.13 0.025 DBMET01181 | DBMET01181 | |
| 0.034 | 0.258 | 0.107 | Sphingosine 1-phosphate receptor antagonist | 0.09 0.03 DBMET01180 0.107 0.018 DBMET01181 | DBMET01181 | |
| 0.164 | 0.389 | 0.553 | Antiinflammatory | 0.346 0.175 DBMET01203 0.485 0.094 DBMET00068 0.325 0.193 DBMET01204 0.35 0.172 DBMET01205 0.553 0.067 DBMET01178 0.492 0.091 DBMET01179 0.328 0.19 DBMET01206 0.382 0.15 DBMET01180 0.494 0.09 DBMET01181 | DBMET01178 | |
| 0.063 | 0.289 | 0.18 | Transcription factor STAT6 inhibitor | 0.18 0.01 DBMET00070 0.124 0.053 DBMET01180 0.121 0.059 DBMET01181 | DBMET00070 | |
| 0.008 | 0.235 | 0.132 | NMDA receptor subunit 3A antagonist | 0.132 0.006 DBMET01180 | DBMET01180 | |
| 0.009 | 0.237 | 0.061 | ATP citrate lysase inhibitor | 0.061 0.005 DBMET01180 0.042 0.011 DBMET01181 | DBMET01180 | |
| 0.042 | 0.27 | 0.3 | NADH dehydrogenase inhibitor | 0.125 0.026 DBMET00070 0.3 0.006 DBMET01180 0.244 0.008 DBMET01181 | DBMET01180 | |
| 0.019 | 0.247 | 0.331 | Phenylalanine 4-hydroxylase inhibitor | 0.116 0.019 DBMET00070 0.331 0.004 DBMET01180 0.188 0.008 DBMET01181 | DBMET01180 | |
| 0.011 | 0.242 | 0.031 | Melatonin 1 agonist | 0.031 0.027 DBMET01181 | DBMET01181 | |
| 0.019 | 0.25 | 0.09 | Cytokine production stimulant | 0.09 0.004 DBMET01181 | DBMET01181 | |
| 0.014 | 0.247 | 0.051 | Cholecystokinin B agonist | 0.051 0.016 DBMET01180 | DBMET01180 | |
| 0.016 | 0.25 | 0.042 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.024 DBMET00070 | DBMET00070 | |
| 0.024 | 0.259 | 0.078 | Metalloproteinase-2 inhibitor | 0.078 0.054 DBMET01181 | DBMET01181 | |
| 0.011 | 0.246 | 0.08 | RNA-directed RNA polymerase inhibitor | 0.08 0.007 DBMET01180 0.053 0.012 DBMET01181 | DBMET01180 | |
| 0.008 | 0.243 | 0.076 | Guanylate cyclase inhibitor | 0.045 0.026 DBMET00070 0.074 0.004 DBMET01180 0.076 0.004 DBMET01181 | DBMET01181 | |
| 0.002 | 0.237 | 0.062 | Prostaglandin EP4 agonist | 0.062 0.004 DBMET01180 0.014 0.011 DBMET01181 | DBMET01180 | |
| 0.002 | 0.239 | 0.028 | Carbonic anhydrase VIII inhibitor | 0.028 0.005 DBMET01180 | DBMET01180 | |
| 0.002 | 0.239 | 0.028 | Carbonic anhydrase X inhibitor | 0.028 0.005 DBMET01180 | DBMET01180 | |
| 0.006 | 0.245 | 0.026 | Alpha 2b adrenoreceptor agonist | 0.026 0.005 DBMET00070 0.022 0.008 DBMET01181 | DBMET00070 | |
| 0.07 | 0.31 | 0.245 | Melanin inhibitor | 0.245 0.029 DBMET00070 0.133 0.108 DBMET01205 0.134 0.107 DBMET01206 0.19 0.045 DBMET01180 0.207 0.038 DBMET01181 | DBMET00070 | |
| 0.004 | 0.245 | 0.073 | Angiotensin AT2 receptor antagonist | 0.073 0.006 DBMET01180 | DBMET01180 | |
| 0.014 | 0.255 | 0.12 | Prostaglandin-E synthase inhibitor | 0.12 0.019 DBMET01180 0.105 0.024 DBMET01181 | DBMET01180 | |
| 0.018 | 0.259 | 0.11 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 DBMET00070 0.11 0.003 DBMET01180 0.056 0.01 DBMET01181 | DBMET01180 | |
| 0.013 | 0.255 | 0.131 | NMDA receptor glycine site agonist | 0.131 0.006 DBMET01180 0.073 0.034 DBMET01181 | DBMET01180 | |
| 0.022 | 0.264 | 0.11 | Topoisomerase II beta inhibitor | 0.077 0.014 DBMET00070 0.11 0.008 DBMET01180 0.105 0.009 DBMET01181 | DBMET01180 | |
| 0.021 | 0.263 | 0.116 | Androgen antagonist | 0.116 0.035 DBMET00070 0.102 0.045 DBMET01181 | DBMET00070 | |
| 0.053 | 0.297 | 0.233 | Glutamate release inhibitor | 0.101 0.041 DBMET00070 0.142 0.012 DBMET01180 0.233 0.004 DBMET01181 | DBMET01181 | |
| 0.005 | 0.251 | 0.051 | Sirtuin 2 inhibitor | 0.034 0.022 DBMET01180 0.051 0.012 DBMET01181 | DBMET01181 | |
| 0.02 | 0.266 | 0.051 | Leukotriene C4 antagonist | 0.051 0.009 DBMET01180 0.044 0.017 DBMET01181 | DBMET01180 | |
| 0.088 | 0.335 | 0.543 | Superoxide dismutase inhibitor | 0.208 0.108 DBMET00069 0.306 0.048 DBMET00070 0.233 0.087 DBMET01205 0.22 0.098 DBMET01179 0.226 0.092 DBMET01206 0.543 0.01 DBMET01180 0.32 0.044 DBMET01181 | DBMET01180 | |
| 0.011 | 0.258 | 0.082 | Mannosidase inhibitor | 0.064 0.014 DBMET01180 0.082 0.008 DBMET01181 | DBMET01181 | |
| 0.002 | 0.249 | 0.043 | G-protein-coupled receptor 120 agonist | 0.026 0.006 DBMET01180 0.043 0.004 DBMET01181 | DBMET01181 | |
| 0.017 | 0.265 | 0.088 | Protein kinase C beta inhibitor | 0.088 0.021 DBMET00070 0.081 0.028 DBMET01180 0.082 0.027 DBMET01181 | DBMET00070 | |
| 0.008 | 0.256 | 0.12 | Ornithine carbamoyltransferase inhibitor | 0.052 0.037 DBMET00070 0.12 0.013 DBMET01180 0.075 0.024 DBMET01181 | DBMET01180 | |
| 0.048 | 0.296 | 0.158 | Antibacterial (Helicobacter pylori) | 0.158 0.04 DBMET00070 0.145 0.05 DBMET01180 0.156 0.041 DBMET01181 | DBMET00070 | |
| 0.093 | 0.342 | 0.361 | DNA synthesis inhibitor | 0.285 0.049 DBMET00070 0.2 0.124 DBMET01179 0.361 0.028 DBMET01180 0.352 0.03 DBMET01181 | DBMET01180 | |
| 0.009 | 0.259 | 0.09 | Thromboxane A2 antagonist | 0.06 0.028 DBMET00070 0.09 0.01 DBMET01180 0.071 0.021 DBMET01181 | DBMET01180 | |
| 0.031 | 0.283 | 0.142 | Peroxisome proliferator-activated receptor gamma antagonist | 0.091 0.022 DBMET00070 0.142 0.006 DBMET01180 0.084 0.028 DBMET01181 | DBMET01180 | |
| 0.036 | 0.288 | 0.22 | GABA receptor agonist | 0.22 0.014 DBMET00070 0.095 0.083 DBMET01180 0.123 0.054 DBMET01181 | DBMET00070 | |
| 0.045 | 0.297 | 0.143 | Microtubule formation inhibitor | 0.112 0.07 DBMET00070 0.136 0.046 DBMET01180 0.143 0.041 DBMET01181 | DBMET01181 | |
| 0.046 | 0.299 | 0.175 | D-Ala-D-Ala ligase inhibitor | 0.11 0.02 DBMET00070 0.175 0.004 DBMET01180 0.125 0.011 DBMET01181 | DBMET01180 | |
| 0.018 | 0.27 | 0.081 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.041 DBMET00070 0.081 0.017 DBMET01180 0.077 0.019 DBMET01181 | DBMET01180 | |
| 0.047 | 0.3 | 0.125 | Cytokine production inhibitor | 0.109 0.101 DBMET01180 0.125 0.084 DBMET01181 | DBMET01181 | |
| 0.03 | 0.284 | 0.075 | Leukotriene C antagonist | 0.075 0.01 DBMET01180 0.066 0.018 DBMET01181 | DBMET01180 | |
| 0.042 | 0.296 | 0.202 | Granulocyte macrophage colony stimulating factor agonist | 0.202 0.003 DBMET00070 0.149 0.005 DBMET01180 0.161 0.004 DBMET01181 | DBMET00070 | |
| 0.002 | 0.257 | 0.012 | Integrin beta2 antagonist | 0.011 0.01 DBMET00070 0.012 0.009 DBMET01180 | DBMET01180 | |
| 0.022 | 0.277 | 0.071 | Metalloproteinase-9 inhibitor | 0.071 0.054 DBMET01181 | DBMET01181 | |
| 0.025 | 0.28 | 0.184 | CD45 antagonist | 0.121 0.007 DBMET00070 0.184 0.005 DBMET01180 0.064 0.018 DBMET01181 | DBMET01180 | |
| 0.003 | 0.26 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 DBMET01180 | DBMET01180 | |
| 0.005 | 0.262 | 0.081 | 5-Alpha-reductase inhibitor | 0.044 0.022 DBMET00070 0.081 0.012 DBMET01180 | DBMET01180 | |
| 0.009 | 0.267 | 0.045 | Glutamate (mGluR1) agonist | 0.045 0.005 DBMET01180 0.029 0.01 DBMET01181 | DBMET01180 | |
| 0.005 | 0.262 | 0.054 | Prostaglandin agonist | 0.054 0.009 DBMET01180 0.038 0.014 DBMET01181 | DBMET01180 | |
| 0.003 | 0.261 | 0.04 | Prostaglandin E2 agonist | 0.04 0.007 DBMET01180 0.028 0.012 DBMET01181 | DBMET01180 | |
| 0.039 | 0.298 | 0.12 | Proteasome inhibitor | 0.105 0.081 DBMET00070 0.107 0.079 DBMET01180 0.12 0.065 DBMET01181 | DBMET01181 | |
| 0.031 | 0.29 | 0.304 | Creatine kinase inhibitor | 0.147 0.025 DBMET00070 0.304 0.004 DBMET01180 0.193 0.012 DBMET01181 | DBMET01180 | |
| 0.005 | 0.264 | 0.105 | Kainate receptor antagonist | 0.058 0.017 DBMET00070 0.105 0.007 DBMET01180 | DBMET01180 | |
| 0.014 | 0.275 | 0.055 | Matrix metalloproteinase (membrane-type) inhibitor | 0.055 0.038 DBMET01181 | DBMET01181 | |
| 0.051 | 0.312 | 0.205 | Interleukin 8 antagonist | 0.205 0.012 DBMET00070 0.138 0.043 DBMET01180 0.105 0.086 DBMET01181 | DBMET00070 | |
| 0.026 | 0.288 | 0.129 | Interferon agonist | 0.087 0.042 DBMET01180 0.129 0.014 DBMET01181 | DBMET01181 | |
| 0.029 | 0.291 | 0.22 | Aminopeptidase B inhibitor | 0.124 0.05 DBMET00070 0.22 0.017 DBMET01180 0.161 0.033 DBMET01181 | DBMET01180 | |
| 0.005 | 0.267 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 DBMET01180 0.023 0.015 DBMET01181 | DBMET01181 | |
| 0.052 | 0.315 | 0.372 | Anesthetic general | 0.372 0.02 DBMET00070 0.285 0.037 DBMET01180 0.281 0.038 DBMET01181 | DBMET00070 | |
| 0.016 | 0.28 | 0.049 | Protein kinase C eta inhibitor | 0.049 0.045 DBMET01180 | DBMET01180 | |
| 0.015 | 0.279 | 0.064 | Matrix metalloproteinase inhibitor | 0.064 0.049 DBMET01181 | DBMET01181 | |
| 0.04 | 0.305 | 0.095 | MDM2 inhibitor | 0.095 0.009 DBMET01180 0.09 0.011 DBMET01181 | DBMET01180 | |
| 0.003 | 0.268 | 0.082 | AMPA 1 receptor antagonist | 0.032 0.019 DBMET00070 0.082 0.007 DBMET01180 | DBMET01180 | |
| 0.014 | 0.279 | 0.301 | Biliverdin reductase inhibitor | 0.1 0.019 DBMET00070 0.301 0.003 DBMET01180 0.166 0.008 DBMET01181 | DBMET01180 | |
| 0.011 | 0.276 | 0.098 | Thromboxane antagonist | 0.059 0.033 DBMET00070 0.098 0.012 DBMET01180 0.074 0.024 DBMET01181 | DBMET01180 | |
| 0.016 | 0.281 | 0.115 | Nicotinic alpha4beta2 receptor antagonist | 0.086 0.044 DBMET00070 0.107 0.026 DBMET01180 0.115 0.02 DBMET01181 | DBMET01181 | |
| 0.006 | 0.272 | 0.03 | 5-Alpha-reductase 2 inhibitor | 0.019 0.014 DBMET00070 0.03 0.009 DBMET01180 | DBMET01180 | |
| 0.006 | 0.273 | 0.033 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.033 0.026 DBMET00070 | DBMET00070 | |
| 0.034 | 0.302 | 0.182 | Mucolytic | 0.163 0.026 DBMET00070 0.182 0.018 DBMET01180 0.18 0.019 DBMET01181 | DBMET01180 | |
| 0.077 | 0.344 | 0.252 | Phospholipase C inhibitor | 0.25 0.025 DBMET00070 0.252 0.025 DBMET01180 0.226 0.031 DBMET01181 | DBMET01180 | |
| 0.026 | 0.294 | 0.105 | Interferon inducer | 0.07 0.035 DBMET01180 0.105 0.011 DBMET01181 | DBMET01181 | |
| 0.036 | 0.306 | 0.418 | Triose-phosphate isomerase inhibitor | 0.182 0.013 DBMET00070 0.418 0.003 DBMET01180 0.324 0.004 DBMET01181 | DBMET01180 | |
| 0.008 | 0.278 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 DBMET01181 | DBMET01181 | |
| 0.005 | 0.275 | 0.09 | Farnesoid X receptor agonist | 0.09 0.004 DBMET01180 0.047 0.017 DBMET01181 | DBMET01180 | |
| 0.018 | 0.289 | 0.065 | Carbonic anhydrase stimulant | 0.065 0.036 DBMET01180 0.056 0.045 DBMET01181 | DBMET01180 | |
| 0.035 | 0.308 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.04 DBMET00070 0.064 0.042 DBMET01180 0.061 0.052 DBMET01181 | DBMET00070 | |
| 0.005 | 0.281 | 0.077 | Free fatty acid receptor 1 antagonist | 0.034 0.023 DBMET00070 0.071 0.004 DBMET01180 0.077 0.004 DBMET01181 | DBMET01181 | |
| 0.011 | 0.287 | 0.05 | Dihydrofolate reductase inhibitor | 0.044 0.03 DBMET01180 0.05 0.019 DBMET01181 | DBMET01181 | |
| 0.013 | 0.29 | 0.136 | Dopamine agonist | 0.076 0.04 DBMET01203 0.072 0.042 DBMET01204 0.136 0.017 DBMET01205 0.129 0.018 DBMET01206 | DBMET01205 | |
| 0.007 | 0.285 | 0.143 | Carbonic anhydrase VB inhibitor | 0.119 0.013 DBMET01180 0.143 0.009 DBMET01181 | DBMET01181 | |
| 0.021 | 0.298 | 0.079 | Beta adrenoreceptor antagonist | 0.059 0.057 DBMET01180 0.079 0.028 DBMET01181 | DBMET01181 | |
| 0.103 | 0.38 | 0.347 | Insulysin inhibitor | 0.257 0.09 DBMET00070 0.347 0.035 DBMET01180 0.274 0.076 DBMET01181 | DBMET01180 | |
| 0.003 | 0.281 | 0.017 | Complement factor D inhibitor | 0.017 0.016 DBMET01181 | DBMET01181 | |
| 0.048 | 0.327 | 0.238 | Cell wall synthesis inhibitor | 0.238 0.019 DBMET01180 0.209 0.027 DBMET01181 | DBMET01180 | |
| 0.004 | 0.285 | 0.041 | Carbonic anhydrase IV inhibitor | 0.041 0.032 DBMET01180 | DBMET01180 | |
| 0.023 | 0.304 | 0.205 | Topoisomerase I inhibitor | 0.205 0.025 DBMET01181 | DBMET01181 | |
| 0.019 | 0.3 | 0.057 | Epithelial sodium channel blocker | 0.057 0.034 DBMET01181 | DBMET01181 | |
| 0.037 | 0.321 | 0.071 | Prolactin release inhibitor | 0.071 0.021 DBMET01181 | DBMET01181 | |
| 0.066 | 0.35 | 0.149 | Pregnane X receptor agonist | 0.144 0.064 DBMET00070 0.14 0.074 DBMET01180 0.149 0.055 DBMET01181 | DBMET01181 | |
| 0.03 | 0.315 | 0.067 | Bcl-xL inhibitor | 0.067 0.025 DBMET00070 0.065 0.028 DBMET01180 0.064 0.03 DBMET01181 | DBMET00070 | |
| 0.017 | 0.302 | 0.14 | Carbonic anhydrase VA inhibitor | 0.14 0.013 DBMET01180 0.125 0.017 DBMET01181 | DBMET01180 | |
| 0.005 | 0.291 | 0.134 | AMPA receptor antagonist | 0.093 0.014 DBMET00070 0.134 0.007 DBMET01180 0.054 0.028 DBMET01181 | DBMET01180 | |
| 0.005 | 0.291 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 DBMET01180 | DBMET01180 | |
| 0.042 | 0.329 | 0.213 | LIM domain kinase 1 inhibitor | 0.213 0.057 DBMET00070 0.15 0.097 DBMET01180 0.142 0.107 DBMET01181 | DBMET00070 | |
| 0.025 | 0.312 | 0.07 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DBMET00070 | DBMET00070 | |
| 0.011 | 0.302 | 0.065 | Acetylcholine M5 receptor agonist | 0.065 0.05 DBMET00070 | DBMET00070 | |
| 0.006 | 0.297 | 0.067 | Glutamate (mGluR1) antagonist | 0.057 0.042 DBMET00070 0.067 0.033 DBMET01180 | DBMET01180 | |
| 0.011 | 0.303 | 0.216 | Argininosuccinate synthase inhibitor | 0.089 0.022 DBMET00070 0.216 0.007 DBMET01180 0.122 0.015 DBMET01181 | DBMET01180 | |
| 0.034 | 0.327 | 0.126 | GABA B receptor agonist | 0.08 0.041 DBMET00070 0.126 0.006 DBMET01180 0.092 0.023 DBMET01181 | DBMET01180 | |
| 0.026 | 0.319 | 0.077 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DBMET01180 0.077 0.026 DBMET01181 | DBMET01181 | |
| 0.009 | 0.302 | 0.072 | Neutrophil collagenase inhibitor | 0.058 0.053 DBMET01180 0.072 0.038 DBMET01181 | DBMET01181 | |
| 0.008 | 0.303 | 0.032 | Melatonin agonist | 0.032 0.023 DBMET01181 | DBMET01181 | |
| 0.043 | 0.339 | 0.294 | Phospholipase A2 inhibitor | 0.161 0.065 DBMET00070 0.294 0.014 DBMET01180 0.191 0.048 DBMET01181 | DBMET01180 | |
| 0.047 | 0.342 | 0.494 | Peroxidase inhibitor | 0.341 0.03 DBMET00070 0.114 0.106 DBMET01205 0.494 0.01 DBMET01180 0.439 0.015 DBMET01181 | DBMET01180 | |
| 0.015 | 0.313 | 0.168 | Sphingosine 1-phosphate receptor 4 agonist | 0.168 0.006 DBMET00070 0.128 0.014 DBMET01180 0.139 0.011 DBMET01181 | DBMET00070 | |
| 0.022 | 0.322 | 0.164 | Purinergic P2X1 antagonist | 0.163 0.005 DBMET00070 0.164 0.005 DBMET01180 0.117 0.012 DBMET01181 | DBMET01180 | |
| 0.042 | 0.344 | 0.23 | DOPA decarboxylase inhibitor | 0.15 0.021 DBMET00070 0.095 0.087 DBMET01205 0.23 0.004 DBMET01180 0.162 0.016 DBMET01181 | DBMET01180 | |
| 0.005 | 0.308 | 0.109 | Dopamine D2 agonist | 0.039 0.036 DBMET01204 0.108 0.01 DBMET01205 0.109 0.01 DBMET01206 | DBMET01206 | |
| 0.022 | 0.326 | 0.119 | Glutamate (mGluR7) antagonist | 0.093 0.015 DBMET00070 0.119 0.005 DBMET01180 0.09 0.018 DBMET01181 | DBMET01180 | |
| 0.011 | 0.316 | 0.072 | Nicotinic receptor alpha3 subunit antagonist | 0.072 0.015 DBMET00070 0.044 0.03 DBMET01180 0.04 0.036 DBMET01181 | DBMET00070 | |
| 0.012 | 0.318 | 0.137 | Carbamoyl phosphate synthetase inhibitor | 0.08 0.028 DBMET00070 0.124 0.015 DBMET01180 0.137 0.013 DBMET01181 | DBMET01181 | |
| 0.014 | 0.32 | 0.077 | Rho-associated kinase I inhibitor | 0.077 0.049 DBMET00070 | DBMET00070 | |
| 0.029 | 0.335 | 0.225 | Keratolytic | 0.069 0.066 DBMET00070 0.225 0.006 DBMET01180 0.148 0.015 DBMET01181 | DBMET01180 | |
| 0.017 | 0.324 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.042 DBMET01181 | DBMET01181 | |
| 0.014 | 0.322 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.036 DBMET01180 | DBMET01180 | |
| 0.023 | 0.333 | 0.059 | Corticotropin releasing factor 2 receptor antagonist | 0.059 0.049 DBMET00070 | DBMET00070 | |
| 0.008 | 0.319 | 0.042 | Integrin alpha2beta1 antagonist | 0.042 0.005 DBMET01180 0.028 0.015 DBMET01181 | DBMET01180 | |
| 0.007 | 0.318 | 0.16 | Nicotinic acid receptor 2 agonist | 0.16 0.004 DBMET01180 | DBMET01180 | |
| 0.013 | 0.325 | 0.154 | Carbonic anhydrase V inhibitor | 0.154 0.014 DBMET01180 0.144 0.016 DBMET01181 | DBMET01180 | |
| 0.002 | 0.315 | 0.016 | Thromboxane A2 agonist | 0.016 0.01 DBMET01180 0.014 0.013 DBMET01181 | DBMET01180 | |
| 0.006 | 0.32 | 0.036 | Epoxide hydrolase 1 inhibitor | 0.036 0.014 DBMET01180 | DBMET01180 | |
| 0.02 | 0.335 | 0.169 | Expectorant | 0.142 0.039 DBMET00070 0.169 0.029 DBMET01180 0.162 0.031 DBMET01181 | DBMET01180 | |
| 0.034 | 0.349 | 0.146 | Nav1.3 sodium channel blocker | 0.146 0.051 DBMET01180 0.124 0.069 DBMET01181 | DBMET01180 | |
| 0.002 | 0.318 | 0.052 | Kainate receptor 1 antagonist | 0.026 0.012 DBMET00070 0.052 0.005 DBMET01180 | DBMET01180 | |
| 0.033 | 0.349 | 0.419 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.156 0.025 DBMET00070 0.419 0.004 DBMET01180 0.367 0.004 DBMET01181 | DBMET01180 | |
| 0.01 | 0.327 | 0.112 | Carbonic anhydrase XIV inhibitor | 0.112 0.008 DBMET01180 0.078 0.017 DBMET01181 | DBMET01180 | |
| 0.042 | 0.359 | 0.204 | Cyclooxygenase 3 inhibitor | 0.204 0.017 DBMET01180 0.172 0.032 DBMET01181 | DBMET01180 | |
| 0.013 | 0.331 | 0.07 | AICAR transformylase inhibitor | 0.043 0.032 DBMET00070 0.07 0.01 DBMET01180 0.054 0.018 DBMET01181 | DBMET01180 | |
| 0.027 | 0.344 | 0.33 | Cystathionine beta-synthase inhibitor | 0.161 0.036 DBMET00070 0.33 0.008 DBMET01180 0.208 0.023 DBMET01181 | DBMET01180 | |
| 0.004 | 0.322 | 0.082 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.02 DBMET01180 0.082 0.004 DBMET01181 | DBMET01181 | |
| 0.012 | 0.333 | 0.046 | Protein kinase (CK2) beta inhibitor | 0.034 0.022 DBMET00070 0.046 0.009 DBMET01180 0.031 0.028 DBMET01181 | DBMET01180 | |
| 0.009 | 0.33 | 0.051 | Liver X receptor agonist | 0.051 0.022 DBMET01181 | DBMET01181 | |
| 0.008 | 0.329 | 0.026 | ICAM 1 antagonist | 0.026 0.011 DBMET00070 0.023 0.017 DBMET01180 0.024 0.014 DBMET01181 | DBMET00070 | |
| 0.022 | 0.344 | 0.05 | Heme oxygenase inhibitor | 0.044 0.025 DBMET00070 0.044 0.025 DBMET01180 0.05 0.013 DBMET01181 | DBMET01181 | |
| 0.014 | 0.337 | 0.057 | Beta 2 adrenoreceptor antagonist | 0.057 0.027 DBMET01181 | DBMET01181 | |
| 0.085 | 0.409 | 0.244 | Immunomodulator | 0.244 0.12 DBMET01181 | DBMET01181 | |
| 0.008 | 0.332 | 0.041 | Thymidine phosphorylase inhibitor | 0.027 0.017 DBMET01180 0.041 0.006 DBMET01181 | DBMET01181 | |
| 0.013 | 0.337 | 0.065 | Beta 1 adrenoreceptor antagonist | 0.065 0.031 DBMET01181 | DBMET01181 | |
| 0.004 | 0.328 | 0.027 | Beta 1 adrenoreceptor agonist | 0.026 0.011 DBMET01180 0.027 0.01 DBMET01181 | DBMET01181 | |
| 0.007 | 0.33 | 0.131 | Aromatase inhibitor | 0.131 0.016 DBMET00070 0.058 0.043 DBMET01180 0.094 0.023 DBMET01181 | DBMET00070 | |
| 0.056 | 0.38 | 0.227 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.137 0.127 DBMET00070 0.227 0.064 DBMET01180 | DBMET01180 | |
| 0.013 | 0.339 | 0.244 | Catalase inhibitor | 0.111 0.035 DBMET00070 0.244 0.009 DBMET01180 0.178 0.02 DBMET01181 | DBMET01180 | |
| 0.003 | 0.329 | 0.019 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.019 0.014 DBMET00070 | DBMET00070 | |
| 0.001 | 0.328 | 0.024 | Glutamate (mGluR6) agonist | 0.024 0.004 DBMET01180 0.013 0.008 DBMET01181 | DBMET01180 | |
| 0.004 | 0.331 | 0.05 | Glutamate (mGluR2) antagonist | 0.05 0.008 DBMET01180 0.05 0.008 DBMET01181 | DBMET01181 | |
| 0.011 | 0.339 | 0.077 | Adenosine deaminase inhibitor | 0.072 0.012 DBMET01180 0.077 0.01 DBMET01181 | DBMET01181 | |
| 0.005 | 0.334 | 0.063 | Estrogen agonist | 0.063 0.029 DBMET01181 | DBMET01181 | |
| 0.028 | 0.357 | 0.115 | Glutathione S-transferase inhibitor | 0.115 0.025 DBMET01180 0.1 0.038 DBMET01181 | DBMET01180 | |
| 0.013 | 0.343 | 0.067 | GABA B receptor antagonist | 0.067 0.009 DBMET00070 0.052 0.018 DBMET01180 0.043 0.03 DBMET01181 | DBMET00070 | |
| 0.02 | 0.349 | 0.338 | Alcohol dehydrogenase inhibitor | 0.195 0.013 DBMET00070 0.338 0.005 DBMET01180 0.164 0.017 DBMET01181 | DBMET01180 | |
| 0.003 | 0.333 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.016 DBMET01180 | DBMET01180 | |
| 0.029 | 0.36 | 0.171 | Glutamate (mGluR6) antagonist | 0.084 0.02 DBMET00070 0.171 0.003 DBMET01180 0.111 0.007 DBMET01181 | DBMET01180 | |
| 0.011 | 0.345 | 0.061 | Potassium channel (Inward rectifier) blocker | 0.061 0.023 DBMET01181 | DBMET01181 | |
| 0.014 | 0.348 | 0.086 | Glutamate (mGluR8) agonist | 0.043 0.018 DBMET00070 0.086 0.004 DBMET01180 0.057 0.008 DBMET01181 | DBMET01180 | |
| 0.002 | 0.338 | 0.043 | Egl nine homolog 3 inhibitor | 0.043 0.003 DBMET01180 | DBMET01180 | |
| 0.005 | 0.343 | 0.066 | Sodium/glucose cotransporter inhibitor | 0.066 0.004 DBMET01181 | DBMET01181 | |
| 0.01 | 0.35 | 0.127 | AMPA 4 receptor antagonist | 0.044 0.02 DBMET00070 0.127 0.004 DBMET01180 0.038 0.031 DBMET01181 | DBMET01180 | |
| 0.006 | 0.346 | 0.038 | LFA antagonist | 0.029 0.017 DBMET00070 0.038 0.009 DBMET01180 0.025 0.024 DBMET01181 | DBMET01180 | |
| 0.005 | 0.347 | 0.056 | Dihydropteroate synthase inhibitor | 0.056 0.013 DBMET01180 | DBMET01180 | |
| 0.01 | 0.352 | 0.056 | Glutamate (mGluR3) agonist | 0.038 0.012 DBMET00070 0.056 0.004 DBMET01180 0.037 0.013 DBMET01181 | DBMET01180 | |
| 0.009 | 0.353 | 0.1 | TRPA1 antagonist | 0.1 0.017 DBMET00070 0.069 0.033 DBMET01180 | DBMET00070 | |
| 0.084 | 0.428 | 0.341 | RNA-directed DNA polymerase inhibitor | 0.22 0.074 DBMET00070 0.287 0.034 DBMET01180 0.341 0.025 DBMET01181 | DBMET01181 | |
| 0.005 | 0.349 | 0.083 | Factor VII inhibitor | 0.083 0.008 DBMET01180 | DBMET01180 | |
| 0.037 | 0.382 | 0.224 | MAP kinase kinase 2 inhibitor | 0.224 0.067 DBMET01180 0.187 0.09 DBMET01181 | DBMET01180 | |
| 0.004 | 0.349 | 0.091 | Kainate receptor 2 antagonist | 0.076 0.007 DBMET00070 0.091 0.005 DBMET01180 | DBMET01180 | |
| 0.049 | 0.395 | 0.146 | P-glycoprotein inhibitor | 0.146 0.124 DBMET01180 | DBMET01180 | |
| 0.011 | 0.358 | 0.147 | NMDA receptor antagonist | 0.147 0.025 DBMET01180 | DBMET01180 | |
| 0.021 | 0.368 | 0.146 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET01180 0.146 0.004 DBMET01181 | DBMET01181 | |
| 0.018 | 0.366 | 0.092 | 5 Hydroxytryptamine 3 agonist | 0.092 0.019 DBMET00070 | DBMET00070 | |
| 0.022 | 0.372 | 0.119 | Myeloperoxidase inhibitor | 0.096 0.04 DBMET01180 0.119 0.02 DBMET01181 | DBMET01181 | |
| 0.01 | 0.36 | 0.061 | Sphingosine kinase 1 inhibitor | 0.061 0.009 DBMET01181 | DBMET01181 | |
| 0.014 | 0.364 | 0.138 | Leukotriene synthesis inhibitor | 0.106 0.023 DBMET01178 0.085 0.034 DBMET01180 0.138 0.011 DBMET01181 | DBMET01181 | |
| 0.01 | 0.36 | 0.154 | Glutamate receptor agonist | 0.106 0.033 DBMET00070 0.154 0.016 DBMET01180 0.082 0.051 DBMET01181 | DBMET01180 | |
| 0.037 | 0.387 | 0.225 | Estrogen antagonist | 0.103 0.092 DBMET01204 0.225 0.01 DBMET00070 0.103 0.092 DBMET01206 0.115 0.065 DBMET01180 0.123 0.05 DBMET01181 | DBMET00070 | |
| 0.033 | 0.384 | 0.096 | MAP kinase kinase 7 inhibitor | 0.073 0.07 DBMET00070 0.093 0.02 DBMET01180 0.096 0.017 DBMET01181 | DBMET01181 | |
| 0.033 | 0.384 | 0.279 | Carbonic anhydrase III inhibitor | 0.086 0.081 DBMET00070 0.279 0.007 DBMET01180 0.208 0.015 DBMET01181 | DBMET01180 | |
| 0.004 | 0.355 | 0.078 | Glutamate (mGluR group II) antagonist | 0.078 0.007 DBMET01180 0.07 0.009 DBMET01181 | DBMET01180 | |
| 0.005 | 0.357 | 0.095 | NMDA 2 receptor antagonist | 0.095 0.035 DBMET01180 | DBMET01180 | |
| 0.045 | 0.398 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | 0.2 0.009 DBMET00070 0.183 0.013 DBMET01180 0.188 0.012 DBMET01181 | DBMET00070 | |
| 0.032 | 0.386 | 0.244 | Electrolyte absorption antagonist | 0.117 0.038 DBMET00070 0.244 0.005 DBMET01180 0.122 0.035 DBMET01181 | DBMET01180 | |
| 0.007 | 0.363 | 0.041 | Glutamate (mGluR5) agonist | 0.041 0.04 DBMET01181 | DBMET01181 | |
| 0.011 | 0.367 | 0.063 | Alpha adrenoreceptor agonist | 0.063 0.052 DBMET01181 | DBMET01181 | |
| 0.036 | 0.393 | 0.093 | Vanilloid agonist | 0.093 0.042 DBMET01205 0.086 0.055 DBMET01206 | DBMET01205 | |
| 0.004 | 0.361 | 0.035 | Endothelin receptor antagonist | 0.035 0.014 DBMET01180 | DBMET01180 | |
| 0.049 | 0.406 | 0.1 | Folate antagonist | 0.1 0.064 DBMET01180 | DBMET01180 | |
| 0.026 | 0.386 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.109 0.047 DBMET00070 0.136 0.024 DBMET01180 0.123 0.033 DBMET01181 | DBMET01180 | |
| 0.028 | 0.387 | 0.157 | Beta glucuronidase inhibitor | 0.157 0.022 DBMET00070 0.132 0.036 DBMET01180 0.114 0.051 DBMET01181 | DBMET00070 | |
| 0.058 | 0.417 | 0.265 | Interferon gamma antagonist | 0.225 0.033 DBMET00070 0.265 0.026 DBMET01180 0.207 0.038 DBMET01181 | DBMET01180 | |
| 0.006 | 0.366 | 0.16 | NMDA receptor subunit 3B antagonist | 0.16 0.005 DBMET01180 0.039 0.037 DBMET01181 | DBMET01180 | |
| 0.011 | 0.372 | 0.059 | Collagenase 3 inhibitor | 0.055 0.048 DBMET01180 0.059 0.042 DBMET01181 | DBMET01181 | |
| 0.023 | 0.384 | 0.074 | Ryanodine receptor antagonist | 0.074 0.013 DBMET01180 0.058 0.043 DBMET01181 | DBMET01180 | |
| 0.013 | 0.375 | 0.077 | Sphingosine 1-phosphate receptor 5 agonist | 0.077 0.014 DBMET01180 0.056 0.033 DBMET01181 | DBMET01180 | |
| 0.003 | 0.367 | 0.04 | NMDA receptor glycine site antagonist | 0.04 0.008 DBMET01180 | DBMET01180 | |
| 0.019 | 0.383 | 0.102 | Dihydroorotate oxidase inhibitor | 0.061 0.028 DBMET00070 0.102 0.005 DBMET01180 0.066 0.021 DBMET01181 | DBMET01180 | |
| 0.003 | 0.368 | 0.06 | Uridine phosphorylase inhibitor | 0.054 0.007 DBMET01180 0.06 0.005 DBMET01181 | DBMET01181 | |
| 0.121 | 0.486 | 0.215 | MAP kinase kinase 3 inhibitor | 0.215 0.085 DBMET00069 0.196 0.133 DBMET01205 0.196 0.133 DBMET01206 | DBMET00069 | |
| 0.01 | 0.377 | 0.056 | Integrin alpha2 antagonist | 0.056 0.008 DBMET01180 0.039 0.022 DBMET01181 | DBMET01180 | |
| 0.013 | 0.381 | 0.104 | Sphingosine kinase 2 inhibitor | 0.051 0.044 DBMET01180 0.104 0.007 DBMET01181 | DBMET01181 | |
| 0.016 | 0.385 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.067 0.047 DBMET01181 | DBMET01181 | |
| 0.026 | 0.395 | 0.106 | MAP kinase kinase 1 inhibitor | 0.106 0.049 DBMET01180 0.101 0.055 DBMET01181 | DBMET01180 | |
| 0.001 | 0.371 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.008 DBMET01180 | DBMET01180 | |
| 0.01 | 0.38 | 0.286 | Dihydroorotase inhibitor | 0.051 0.023 DBMET00070 0.286 0.003 DBMET01180 0.063 0.015 DBMET01181 | DBMET01180 | |
| 0.005 | 0.377 | 0.069 | AMPA 2 receptor antagonist | 0.069 0.008 DBMET01180 | DBMET01180 | |
| 0.007 | 0.38 | 0.054 | Liver X receptor alpha antagonist | 0.033 0.015 DBMET01180 0.054 0.005 DBMET01181 | DBMET01181 | |
| 0.033 | 0.406 | 0.161 | Interleukin 1b antagonist | 0.161 0.033 DBMET01180 0.159 0.034 DBMET01181 | DBMET01180 | |
| 0.036 | 0.411 | 0.12 | Nav1.1 sodium channel blocker | 0.11 0.056 DBMET01180 0.12 0.048 DBMET01181 | DBMET01181 | |
| 0.045 | 0.422 | 0.318 | Hexokinase inhibitor | 0.129 0.105 DBMET00070 0.318 0.009 DBMET01180 0.227 0.023 DBMET01181 | DBMET01180 | |
| 0.006 | 0.383 | 0.056 | Calcium release-activated channel blocker | 0.056 0.008 DBMET00070 | DBMET00070 | |
| 0.009 | 0.387 | 0.095 | Benzodiazepine agonist | 0.095 0.029 DBMET00070 | DBMET00070 | |
| 0.045 | 0.425 | 0.364 | Interleukin agonist | 0.177 0.142 DBMET00070 0.335 0.034 DBMET01180 0.364 0.025 DBMET01181 | DBMET01181 | |
| 0.005 | 0.386 | 0.035 | Dopamine D3 agonist | 0.035 0.034 DBMET00070 | DBMET00070 | |
| 0.04 | 0.422 | 0.085 | Ca(v)3.1 blocker | 0.085 0.047 DBMET00069 | DBMET00069 | |
| 0.024 | 0.408 | 0.193 | Carbonic anhydrase VI inhibitor | 0.187 0.015 DBMET01180 0.193 0.014 DBMET01181 | DBMET01181 | |
| 0.008 | 0.393 | 0.05 | Pim-2 kinase inhibitor | 0.05 0.046 DBMET00070 | DBMET00070 | |
| 0.005 | 0.391 | 0.115 | Beta tubulin antagonist | 0.115 0.019 DBMET00070 | DBMET00070 | |
| 0.006 | 0.392 | 0.043 | Glutamate (mGluR group I) agonist | 0.043 0.039 DBMET01180 0.043 0.039 DBMET01181 | DBMET01181 | |
| 0.035 | 0.422 | 0.208 | NADPH oxidase inhibitor | 0.208 0.032 DBMET01180 0.128 0.074 DBMET01181 | DBMET01180 | |
| 0.04 | 0.428 | 0.335 | Free radical scavenger | 0.311 0.049 DBMET01203 0.283 0.056 DBMET01204 0.237 0.074 DBMET00070 0.335 0.043 DBMET01205 0.309 0.049 DBMET01206 0.221 0.083 DBMET01180 0.162 0.131 DBMET01181 | DBMET01205 | |
| 0.007 | 0.394 | 0.16 | Glutamate (mGluR3) antagonist | 0.16 0.004 DBMET01180 0.063 0.007 DBMET01181 | DBMET01180 | |
| 0.006 | 0.395 | 0.057 | Toll-Like receptor 8 antagonist | 0.057 0.034 DBMET01181 | DBMET01181 | |
| 0.033 | 0.422 | 0.134 | Thioredoxin reductase inhibitor | 0.084 0.051 DBMET00070 0.077 0.072 DBMET01180 0.134 0.013 DBMET01181 | DBMET01181 | |
| 0.037 | 0.426 | 0.137 | Interleukin 1 antagonist | 0.137 0.068 DBMET01180 0.13 0.076 DBMET01181 | DBMET01180 | |
| 0.011 | 0.401 | 0.09 | Sphingosine kinase inhibitor | 0.056 0.047 DBMET01180 0.09 0.01 DBMET01181 | DBMET01181 | |
| 0.052 | 0.442 | 0.12 | Factor V inhibitor | 0.111 0.05 DBMET00070 0.12 0.039 DBMET01180 | DBMET01180 | |
| 0.004 | 0.395 | 0.063 | HCV NS5B polymerase inhibitor | 0.063 0.008 DBMET01180 0.044 0.012 DBMET01181 | DBMET01180 | |
| 0.028 | 0.42 | 0.129 | Bile acid receptor antagonist | 0.129 0.014 DBMET01180 0.111 0.03 DBMET01181 | DBMET01180 | |
| 0.002 | 0.394 | 0.036 | Egl nine homolog 1 inhibitor | 0.036 0.004 DBMET01180 | DBMET01180 | |
| 0.01 | 0.402 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.05 DBMET00070 | DBMET00070 | |
| 0.092 | 0.485 | 0.295 | Nitric-oxide synthase stimulant | 0.216 0.065 DBMET00070 0.228 0.051 DBMET01180 0.295 0.013 DBMET01181 | DBMET01181 | |
| 0.016 | 0.409 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 DBMET01180 0.052 0.048 DBMET01181 | DBMET01180 | |
| 0.004 | 0.398 | 0.059 | Carbonic anhydrase II inhibitor | 0.059 0.036 DBMET01180 | DBMET01180 | |
| 0.053 | 0.449 | 0.223 | CF transmembrane conductance regulator agonist | 0.165 0.052 DBMET00070 0.179 0.037 DBMET01180 0.223 0.012 DBMET01181 | DBMET01181 | |
| 0.014 | 0.411 | 0.052 | Beta adrenoreceptor agonist | 0.048 0.021 DBMET01180 0.052 0.014 DBMET01181 | DBMET01181 | |
| 0.037 | 0.434 | 0.111 | Glutamate (mGluR7) agonist | 0.099 0.061 DBMET00070 0.111 0.041 DBMET01180 0.111 0.04 DBMET01181 | DBMET01181 | |
| 0.004 | 0.403 | 0.054 | Fructose-1,6-bisphosphatase inhibitor | 0.054 0.022 DBMET01180 | DBMET01180 | |
| 0.056 | 0.458 | 0.338 | Transcription factor NF kappa B inhibitor | 0.338 0.081 DBMET00070 0.305 0.091 DBMET01180 0.315 0.087 DBMET01181 | DBMET00070 | |
| 0.019 | 0.424 | 0.192 | GABA A receptor agonist | 0.192 0.011 DBMET00070 0.092 0.046 DBMET01181 | DBMET00070 | |
| 0.059 | 0.464 | 0.324 | Hypoxia-inducible factor 1 alpha inhibitor | 0.209 0.142 DBMET00070 0.324 0.055 DBMET01180 0.286 0.072 DBMET01181 | DBMET01180 | |
| 0.033 | 0.44 | 0.18 | Heat shock protein 90 antagonist | 0.18 0.049 DBMET00070 0.133 0.093 DBMET01180 0.118 0.117 DBMET01181 | DBMET00070 | |
| 0.032 | 0.439 | 0.259 | Mannose-6-phosphate isomerase inhibitor | 0.244 0.014 DBMET00070 0.253 0.011 DBMET01180 0.259 0.01 DBMET01181 | DBMET01181 | |
| 0.06 | 0.468 | 0.206 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 DBMET00070 0.206 0.009 DBMET01180 0.167 0.037 DBMET01181 | DBMET01180 | |
| 0.016 | 0.425 | 0.078 | Heparanase inhibitor | 0.078 0.007 DBMET01180 0.065 0.016 DBMET01181 | DBMET01180 | |
| 0.016 | 0.427 | 0.216 | Carbonic anhydrase XIII inhibitor | 0.113 0.032 DBMET00070 0.216 0.012 DBMET01180 0.157 0.02 DBMET01181 | DBMET01180 | |
| 0.075 | 0.486 | 0.351 | Sodium/bile acid cotransporter inhibitor | 0.221 0.161 DBMET01205 0.229 0.151 DBMET01178 0.211 0.174 DBMET01206 0.351 0.039 DBMET01180 0.197 0.192 DBMET01181 | DBMET01180 | |
| 0.051 | 0.464 | 0.349 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.349 0.004 DBMET01180 | DBMET01180 | |
| 0.022 | 0.436 | 0.138 | 5 Hydroxytryptamine 3A agonist | 0.138 0.043 DBMET00070 0.099 0.078 DBMET01180 0.104 0.072 DBMET01181 | DBMET00070 | |
| 0.014 | 0.428 | 0.068 | I kappa B kinase 2 inhibitor | 0.068 0.034 DBMET01181 | DBMET01181 | |
| 0.005 | 0.42 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | 0.041 0.02 DBMET00070 | DBMET00070 | |
| 0.017 | 0.432 | 0.124 | Ca(v)2.2 blocker | 0.124 0.037 DBMET00070 | DBMET00070 | |
| 0.018 | 0.434 | 0.157 | Mediator release inhibitor | 0.157 0.026 DBMET01180 0.089 0.083 DBMET01181 | DBMET01180 | |
| 0.011 | 0.426 | 0.332 | Histidine decarboxylase inhibitor | 0.276 0.007 DBMET00070 0.332 0.005 DBMET01180 0.306 0.006 DBMET01181 | DBMET01180 | |
| 0.003 | 0.419 | 0.028 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 DBMET01180 | DBMET01180 | |
| 0.014 | 0.433 | 0.062 | Aryl hydrocarbon receptor antagonist | 0.061 0.051 DBMET00070 0.062 0.049 DBMET01181 | DBMET01181 | |
| 0.059 | 0.478 | 0.332 | Antithrombotic | 0.332 0.071 DBMET01180 0.309 0.082 DBMET01181 | DBMET01180 | |
| 0.004 | 0.431 | 0.029 | Cholecystokinin A agonist | 0.029 0.006 DBMET01180 | DBMET01180 | |
| 0.006 | 0.434 | 0.13 | Nicotinic acid receptor agonist | 0.044 0.017 DBMET00070 0.13 0.004 DBMET01180 0.045 0.017 DBMET01181 | DBMET01180 | |
| 0.019 | 0.448 | 0.168 | Protein kinase C gamma inhibitor | 0.16 0.026 DBMET00070 0.168 0.023 DBMET01180 0.158 0.027 DBMET01181 | DBMET01180 | |
| 0.002 | 0.433 | 0.046 | Nicotinic acid receptor 1 antagonist | 0.046 0.003 DBMET01180 0.017 0.013 DBMET01181 | DBMET01180 | |
| 0.004 | 0.438 | 0.075 | Carbonic anhydrase inhibitor | 0.075 0.037 DBMET01180 | DBMET01180 | |
| 0.003 | 0.438 | 0.066 | Carbonic anhydrase I inhibitor | 0.066 0.031 DBMET01180 | DBMET01180 | |
| 0.003 | 0.439 | 0.063 | Glutamate (mGluR1a) agonist | 0.03 0.009 DBMET00070 0.063 0.004 DBMET01180 0.029 0.009 DBMET01181 | DBMET01180 | |
| 0.046 | 0.481 | 0.297 | Cyclic AMP phosphodiesterase inhibitor | 0.297 0.043 DBMET01180 0.265 0.057 DBMET01181 | DBMET01180 | |
| 0.018 | 0.453 | 0.208 | Potassium channel (Ca-activated) activator | 0.208 0.013 DBMET01180 0.097 0.058 DBMET01181 | DBMET01180 | |
| 0.028 | 0.466 | 0.114 | Nav1.4 sodium channel blocker | 0.114 0.058 DBMET01181 | DBMET01181 | |
| 0.012 | 0.449 | 0.128 | Protein kinase C zeta inhibitor | 0.128 0.028 DBMET00070 0.089 0.067 DBMET01180 0.107 0.043 DBMET01181 | DBMET00070 | |
| 0.038 | 0.476 | 0.274 | Non-steroidal antiinflammatory agent | 0.274 0.034 DBMET01180 0.236 0.049 DBMET01181 | DBMET01180 | |
| 0.007 | 0.446 | 0.141 | Xanthine dehydrogenase inhibitor | 0.086 0.021 DBMET00070 0.141 0.008 DBMET01180 0.102 0.015 DBMET01181 | DBMET01180 | |
| 0.001 | 0.441 | 0.015 | Thrombopoietin agonist | 0.015 0.005 DBMET01180 | DBMET01180 | |
| 0.008 | 0.449 | 0.195 | Monophenol monooxygenase inhibitor | 0.189 0.036 DBMET00070 0.195 0.034 DBMET01180 0.176 0.039 DBMET01181 | DBMET01180 | |
| 0.096 | 0.538 | 0.661 | 5 Hydroxytryptamine release inhibitor | 0.397 0.08 DBMET00070 0.661 0.005 DBMET01180 0.461 0.047 DBMET01181 | DBMET01180 | |
| 0.003 | 0.446 | 0.111 | Urate transporter 1 inhibitor | 0.111 0.005 DBMET01180 0.063 0.013 DBMET01181 | DBMET01180 | |
| 0.016 | 0.459 | 0.148 | Macrophage migration inhibitory factor inhibitor | 0.116 0.027 DBMET00070 0.148 0.016 DBMET01180 0.108 0.031 DBMET01181 | DBMET01180 | |
| 0.045 | 0.489 | 0.154 | DNA repair enzyme inhibitor | 0.111 0.093 DBMET00070 0.139 0.042 DBMET01180 0.154 0.028 DBMET01181 | DBMET01181 | |
| 0.003 | 0.449 | 0.039 | Orexin receptor 2 antagonist | 0.039 0.022 DBMET00070 | DBMET00070 | |
| 0.035 | 0.482 | 0.156 | Sphingosine 1-phosphate receptor 2 antagonist | 0.156 0.034 DBMET01180 0.151 0.04 DBMET01181 | DBMET01180 | |
| 0.004 | 0.453 | 0.026 | Cholecystokinin agonist | 0.026 0.01 DBMET01180 | DBMET01180 | |
| 0.027 | 0.477 | 0.11 | Bromodomain-containing protein 2 inhibitor | 0.09 0.055 DBMET01180 0.11 0.03 DBMET01181 | DBMET01181 | |
| 0.043 | 0.497 | 0.36 | 3C-like protease (Human coronavirus) inhibitor | 0.36 0.005 DBMET00070 0.318 0.008 DBMET01180 0.193 0.056 DBMET01181 | DBMET00070 | |
| 0.005 | 0.459 | 0.043 | Leukocyte elastase inhibitor | 0.043 0.029 DBMET00070 | DBMET00070 | |
| 0.028 | 0.482 | 0.13 | Activin receptor-like kinase 2 inhibitor | 0.13 0.085 DBMET01181 | DBMET01181 | |
| 0.04 | 0.495 | 0.312 | 12-Lipoxygenase inhibitor | 0.285 0.089 DBMET00070 0.3 0.08 DBMET01180 0.312 0.073 DBMET01181 | DBMET01181 | |
| 0.018 | 0.473 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.095 DBMET00070 | DBMET00070 | |
| 0.014 | 0.471 | 0.129 | Urease inhibitor | 0.129 0.037 DBMET01180 0.102 0.065 DBMET01181 | DBMET01180 | |
| 0.023 | 0.482 | 0.174 | Toll-Like receptor antagonist | 0.174 0.041 DBMET00070 0.122 0.081 DBMET01181 | DBMET00070 | |
| 0.009 | 0.47 | 0.09 | Neuraminidase (Influenza A) inhibitor | 0.09 0.004 DBMET01180 | DBMET01180 | |
| 0.005 | 0.467 | 0.029 | Thyroid hormone agonist | 0.029 0.014 DBMET01181 | DBMET01181 | |
| 0.01 | 0.476 | 0.051 | Potassium channel (ATP-sensitive) activator | 0.051 0.028 DBMET00070 | DBMET00070 | |
| 0.057 | 0.524 | 0.595 | Histamine release inhibitor | 0.314 0.116 DBMET00070 0.595 0.01 DBMET01180 0.454 0.048 DBMET01181 | DBMET01180 | |
| 0.014 | 0.481 | 0.115 | MAP kinase kinase inhibitor | 0.115 0.079 DBMET01181 | DBMET01181 | |
| 0.004 | 0.472 | 0.101 | Phosphorylase inhibitor | 0.054 0.028 DBMET00070 0.101 0.013 DBMET01180 0.075 0.018 DBMET01181 | DBMET01180 | |
| 0.01 | 0.479 | 0.054 | Potassium channel (Inward rectifier) activator | 0.054 0.029 DBMET00070 0.046 0.045 DBMET01181 | DBMET00070 | |
| 0.013 | 0.484 | 0.056 | Aldosterone antagonist | 0.056 0.023 DBMET01180 | DBMET01180 | |
| 0.004 | 0.475 | 0.054 | Carbonic anhydrase VII inhibitor | 0.054 0.023 DBMET01180 | DBMET01180 | |
| 0.003 | 0.475 | 0.066 | Kynurenine 3 monooxygenase inhibitor | 0.066 0.005 DBMET01180 0.023 0.022 DBMET01181 | DBMET01180 | |
| 0.023 | 0.495 | 0.264 | Xanthine oxidase inhibitor | 0.188 0.022 DBMET00070 0.264 0.011 DBMET01180 0.16 0.031 DBMET01181 | DBMET01180 | |
| 0.029 | 0.503 | 0.268 | Calpain inhibitor | 0.268 0.049 DBMET00070 0.196 0.117 DBMET01180 0.181 0.134 DBMET01181 | DBMET00070 | |
| 0.012 | 0.486 | 0.076 | Cyclin D1 inhibitor | 0.056 0.05 DBMET01180 0.076 0.022 DBMET01181 | DBMET01181 | |
| 0.005 | 0.48 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | 0.045 0.044 DBMET00070 | DBMET00070 | |
| 0.07 | 0.55 | 0.386 | Calcium channel activator | 0.301 0.091 DBMET00070 0.386 0.03 DBMET01180 0.371 0.037 DBMET01181 | DBMET01180 | |
| 0.003 | 0.483 | 0.065 | Carbonic anhydrase XII inhibitor | 0.065 0.031 DBMET01180 | DBMET01180 | |
| 0.026 | 0.505 | 0.111 | mTOR complex 2 inhibitor | 0.085 0.056 DBMET01180 0.111 0.023 DBMET01181 | DBMET01181 | |
| 0.034 | 0.517 | 0.29 | Lipoxygenase inhibitor | 0.196 0.145 DBMET00070 0.27 0.087 DBMET01180 0.29 0.076 DBMET01181 | DBMET01181 | |
| 0.011 | 0.494 | 0.147 | Adrenaline agonist | 0.098 0.038 DBMET01180 0.147 0.015 DBMET01181 | DBMET01181 | |
| 0.01 | 0.493 | 0.096 | CDC25A inhibitor | 0.096 0.03 DBMET01203 0.094 0.031 DBMET01204 0.094 0.031 DBMET01205 0.092 0.033 DBMET01206 0.096 0.03 DBMET01180 0.068 0.06 DBMET01181 | DBMET01180 | |
| 0.015 | 0.5 | 0.128 | DNA intercalator | 0.128 0.053 DBMET01181 | DBMET01181 | |
| 0.032 | 0.518 | 0.283 | DNA methylase inhibitor | 0.283 0.033 DBMET01180 0.15 0.117 DBMET01181 | DBMET01180 | |
| 0.019 | 0.505 | 0.163 | AMP-activated protein kinase stimulant | 0.092 0.083 DBMET00070 0.163 0.021 DBMET01180 0.145 0.031 DBMET01181 | DBMET01180 | |
| 0.011 | 0.498 | 0.073 | Orexin receptor antagonist | 0.073 0.036 DBMET00070 | DBMET00070 | |
| 0.015 | 0.504 | 0.091 | Caspase 7 inhibitor | 0.091 0.039 DBMET01180 0.075 0.073 DBMET01181 | DBMET01180 | |
| 0.014 | 0.504 | 0.04 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 DBMET00070 0.04 0.01 DBMET01180 | DBMET01180 | |
| 0.019 | 0.509 | 0.075 | Phosphodiesterase 1C inhibitor | 0.063 0.042 DBMET01180 0.075 0.024 DBMET01181 | DBMET01181 | |
| 0.021 | 0.512 | 0.219 | I kappa B kinase epsilon inhibitor | 0.219 0.056 DBMET01180 0.174 0.095 DBMET01181 | DBMET01180 | |
| 0.022 | 0.514 | 0.077 | Falcipain 2 inhibitor | 0.077 0.073 DBMET00070 | DBMET00070 | |
| 0.013 | 0.507 | 0.086 | Orexin receptor 1 antagonist | 0.086 0.026 DBMET00070 | DBMET00070 | |
| 0.022 | 0.519 | 0.08 | Falcipain inhibitor | 0.08 0.074 DBMET00070 | DBMET00070 | |
| 0.025 | 0.523 | 0.226 | Heat shock protein 90 alpha antagonist | 0.226 0.036 DBMET00070 0.179 0.063 DBMET01180 | DBMET00070 | |
| 0.012 | 0.512 | 0.169 | Glutamate (mGluR group III) antagonist | 0.065 0.011 DBMET00070 0.169 0.003 DBMET01180 0.05 0.02 DBMET01181 | DBMET01180 | |
| 0.013 | 0.512 | 0.078 | I kappa B kinase inhibitor | 0.078 0.063 DBMET01181 | DBMET01181 | |
| 0.003 | 0.502 | 0.074 | Carbonic anhydrase IX inhibitor | 0.074 0.03 DBMET01180 | DBMET01180 | |
| 0.003 | 0.503 | 0.032 | Prostaglandin EP3 antagonist | 0.027 0.024 DBMET01180 0.032 0.019 DBMET01181 | DBMET01181 | |
| 0.008 | 0.509 | 0.082 | Diacylglycerol O-acyltransferase inhibitor | 0.082 0.013 DBMET01180 0.047 0.04 DBMET01181 | DBMET01180 | |
| 0.013 | 0.514 | 0.152 | Glutamate (mGluR4) antagonist | 0.069 0.01 DBMET00070 0.152 0.004 DBMET01180 0.047 0.024 DBMET01181 | DBMET01180 | |
| 0.005 | 0.508 | 0.066 | Glutamate (mGluR) agonist | 0.066 0.04 DBMET01180 | DBMET01180 | |
| 0.022 | 0.525 | 0.265 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.265 0.074 DBMET01180 | DBMET01180 | |
| 0.062 | 0.565 | 0.228 | Catenin beta inhibitor | 0.228 0.017 DBMET01180 | DBMET01180 | |
| 0.039 | 0.543 | 0.192 | Tumour necrosis factor antagonist | 0.144 0.108 DBMET01180 0.192 0.058 DBMET01181 | DBMET01181 | |
| 0.044 | 0.556 | 0.253 | Antiobesity | 0.253 0.154 DBMET01181 | DBMET01181 | |
| 0.007 | 0.519 | 0.108 | Pim-3 kinase inhibitor | 0.108 0.038 DBMET00070 | DBMET00070 | |
| 0.003 | 0.518 | 0.043 | Carnitine palmitoyltransferase inhibitor | 0.043 0.013 DBMET01180 | DBMET01180 | |
| 0.006 | 0.524 | 0.053 | Factor VIIa inhibitor | 0.053 0.019 DBMET01180 | DBMET01180 | |
| 0.035 | 0.555 | 0.322 | Transcription factor STAT3 inhibitor | 0.322 0.043 DBMET01180 0.217 0.114 DBMET01181 | DBMET01180 | |
| 0.004 | 0.526 | 0.061 | Purinergic P2Y antagonist | 0.039 0.038 DBMET00070 0.061 0.019 DBMET01180 | DBMET01180 | |
| 0.012 | 0.535 | 0.111 | Prostaglandin F2 alpha antagonist | 0.111 0.008 DBMET01180 | DBMET01180 | |
| 0.08 | 0.606 | 0.174 | Peptidyltransferase inhibitor | 0.174 0.139 DBMET01180 | DBMET01180 | |
| 0.004 | 0.531 | 0.057 | Glutamate (mGluR2) agonist | 0.057 0.012 DBMET01180 | DBMET01180 | |
| 0.038 | 0.566 | 0.253 | Hepatoprotectant | 0.15 0.11 DBMET00070 0.253 0.042 DBMET01180 0.252 0.043 DBMET01181 | DBMET01180 | |
| 0 | 0.531 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DBMET01180 | DBMET01180 | |
| 0.005 | 0.536 | 0.169 | Prostaglandin EP2 antagonist | 0.169 0.008 DBMET01180 0.135 0.012 DBMET01181 | DBMET01180 | |
| 0.024 | 0.557 | 0.377 | Amylase inhibitor | 0.155 0.062 DBMET00070 0.263 0.025 DBMET01180 0.377 0.011 DBMET01181 | DBMET01181 | |
| 0.003 | 0.536 | 0.034 | Angiotensin AT1A receptor antagonist | 0.034 0.005 DBMET01180 | DBMET01180 | |
| 0.015 | 0.55 | 0.155 | Caspase 3 inhibitor | 0.135 0.041 DBMET00070 0.155 0.025 DBMET01180 0.117 0.064 DBMET01181 | DBMET01180 | |
| 0.003 | 0.538 | 0.038 | G protein-coupled receptor agonist | 0.038 0.027 DBMET01181 | DBMET01181 | |
| 0.021 | 0.556 | 0.117 | Adenine nucleotide translocase inhibitor | 0.117 0.004 DBMET01180 0.06 0.028 DBMET01181 | DBMET01180 | |
| 0.023 | 0.558 | 0.174 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.174 0.1 DBMET01180 | DBMET01180 | |
| 0.018 | 0.556 | 0.19 | Anticonvulsant | 0.166 0.111 DBMET00070 0.144 0.136 DBMET01180 0.19 0.09 DBMET01181 | DBMET01181 | |
| 0.018 | 0.559 | 0.149 | Anticoagulant | 0.149 0.081 DBMET01180 | DBMET01180 | |
| 0.007 | 0.549 | 0.041 | MAP3K5 inhibitor | 0.041 0.023 DBMET01181 | DBMET01181 | |
| 0.013 | 0.554 | 0.115 | Glucose-6-phosphate translocase inhibitor | 0.115 0.005 DBMET00070 | DBMET00070 | |
| 0.031 | 0.573 | 0.165 | Focal adhesion kinase 2 inhibitor | 0.154 0.124 DBMET00070 0.165 0.107 DBMET01180 | DBMET01180 | |
| 0.003 | 0.545 | 0.02 | Calcium-sensing receptor antagonist | 0.02 0.008 DBMET00070 | DBMET00070 | |
| 0.03 | 0.573 | 0.126 | Transcription factor NF kappa B stimulant | 0.126 0.023 DBMET01181 | DBMET01181 | |
| 0.005 | 0.549 | 0.065 | Glutamate (mGluR group II) agonist | 0.065 0.011 DBMET01180 | DBMET01180 | |
| 0.01 | 0.554 | 0.079 | Purinergic P2X4 antagonist | 0.079 0.007 DBMET00070 0.047 0.029 DBMET01180 0.046 0.032 DBMET01181 | DBMET00070 | |
| 0.011 | 0.556 | 0.051 | Aggrecanase 1 inhibitor | 0.051 0.013 DBMET01181 | DBMET01181 | |
| 0.004 | 0.557 | 0.05 | Peroxisome proliferator-activated receptor delta antagonist | 0.05 0.01 DBMET01180 | DBMET01180 | |
| 0.019 | 0.573 | 0.128 | Nav1.5 sodium channel blocker | 0.128 0.045 DBMET01181 | DBMET01181 | |
| 0.094 | 0.652 | 0.567 | Calcium channel L-type activator | 0.235 0.222 DBMET00070 0.516 0.022 DBMET01180 0.567 0.01 DBMET01181 | DBMET01181 | |
| 0.016 | 0.574 | 0.058 | Phosphodiesterase 1B inhibitor | 0.058 0.044 DBMET01181 | DBMET01181 | |
| 0.003 | 0.564 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.014 DBMET01180 | DBMET01180 | |
| 0.033 | 0.596 | 0.232 | Histone acetyltransferase inhibitor | 0.196 0.076 DBMET00070 0.232 0.035 DBMET01180 0.166 0.118 DBMET01181 | DBMET01180 | |
| 0.011 | 0.578 | 0.168 | Cytidine deaminase inhibitor | 0.165 0.065 DBMET01180 0.168 0.063 DBMET01181 | DBMET01181 | |
| 0.004 | 0.573 | 0.035 | Prostaglandin D2 agonist | 0.035 0.017 DBMET01180 0.03 0.022 DBMET01181 | DBMET01180 | |
| 0.02 | 0.59 | 0.301 | DNA methyltransferase I inhibitor | 0.14 0.115 DBMET00070 0.301 0.026 DBMET01180 0.148 0.107 DBMET01181 | DBMET01180 | |
| 0.004 | 0.575 | 0.064 | Nav1.7 sodium channel blocker | 0.064 0.051 DBMET01181 | DBMET01181 | |
| 0.036 | 0.607 | 0.317 | Transcription factor STAT inhibitor | 0.256 0.083 DBMET00070 0.317 0.047 DBMET01180 0.207 0.128 DBMET01181 | DBMET01180 | |
| 0.007 | 0.579 | 0.147 | 5-Lipoxygenase inhibitor | 0.139 0.042 DBMET01180 0.147 0.039 DBMET01181 | DBMET01181 | |
| 0.006 | 0.578 | 0.042 | Glutamate (mGluR4) agonist | 0.042 0.014 DBMET01180 | DBMET01180 | |
| 0.007 | 0.58 | 0.067 | Bcl2 antagonist | 0.061 0.053 DBMET00070 0.067 0.046 DBMET01180 0.059 0.057 DBMET01181 | DBMET01180 | |
| 0.035 | 0.608 | 0.341 | Immunosuppressant | 0.341 0.092 DBMET01180 0.288 0.123 DBMET01181 | DBMET01180 | |
| 0.004 | 0.586 | 0.096 | Antineoplastic antibiotic | 0.096 0.048 DBMET00070 | DBMET00070 | |
| 0.013 | 0.596 | 0.189 | Alkaline phosphatase inhibitor | 0.189 0.038 DBMET00070 0.162 0.052 DBMET01180 0.112 0.096 DBMET01181 | DBMET00070 | |
| 0.011 | 0.596 | 0.498 | Aryl hydrocarbon receptor agonist | 0.498 0.024 DBMET00070 0.228 0.088 DBMET01180 0.215 0.094 DBMET01181 | DBMET00070 | |
| 0.003 | 0.589 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 DBMET01180 | DBMET01180 | |
| 0.004 | 0.591 | 0.155 | Protein kinase (CK2) inhibitor | 0.155 0.031 DBMET01180 | DBMET01180 | |
| 0.004 | 0.595 | 0.202 | Dihydroorotate dehydrogenase inhibitor | 0.063 0.026 DBMET00070 0.202 0.004 DBMET01180 0.094 0.013 DBMET01181 | DBMET01180 | |
| 0.008 | 0.599 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.064 DBMET01181 | DBMET01181 | |
| 0.038 | 0.63 | 0.159 | MAP kinase 3 inhibitor | 0.132 0.102 DBMET01180 0.159 0.055 DBMET01181 | DBMET01181 | |
| 0.027 | 0.622 | 0.27 | 15-Lipoxygenase inhibitor | 0.27 0.149 DBMET00070 0.259 0.158 DBMET01180 0.252 0.163 DBMET01181 | DBMET00070 | |
| 0.004 | 0.607 | 0.036 | AMPA receptor agonist | 0.032 0.031 DBMET01180 0.036 0.024 DBMET01181 | DBMET01181 | |
| 0.005 | 0.608 | 0.226 | Prostaglandin antagonist | 0.226 0.005 DBMET01180 0.053 0.037 DBMET01181 | DBMET01180 | |
| 0.009 | 0.618 | 0.109 | Sodium channel blocker | 0.109 0.099 DBMET01181 | DBMET01181 | |
| 0.007 | 0.619 | 0.066 | Maillard reaction inhibitor | 0.066 0.031 DBMET01180 | DBMET01180 | |
| 0.028 | 0.64 | 0.134 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.067 DBMET00070 0.134 0.014 DBMET01180 | DBMET01180 | |
| 0.02 | 0.635 | 0.145 | Neuropeptide Y1 antagonist | 0.145 0.073 DBMET01180 | DBMET01180 | |
| 0.021 | 0.637 | 0.367 | Calpain 2 inhibitor | 0.367 0.078 DBMET00070 0.212 0.177 DBMET01180 | DBMET00070 | |
| 0.01 | 0.627 | 0.273 | Estrogen receptor beta antagonist | 0.273 0.006 DBMET00070 0.106 0.053 DBMET01180 0.109 0.048 DBMET01181 | DBMET00070 | |
| 0.019 | 0.636 | 0.235 | Vasodilator | 0.235 0.078 DBMET01181 | DBMET01181 | |
| 0.009 | 0.627 | 0.225 | Purinergic P2X2 antagonist | 0.225 0.004 DBMET00070 | DBMET00070 | |
| 0 | 0.618 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.004 DBMET01180 | DBMET01180 | |
| 0.017 | 0.645 | 0.084 | Phosphodiesterase I inhibitor | 0.084 0.07 DBMET01181 | DBMET01181 | |
| 0.004 | 0.637 | 0.165 | Protein kinase (CK2) alpha inhibitor | 0.165 0.034 DBMET01180 | DBMET01180 | |
| 0.004 | 0.64 | 0.041 | Purinergic P2X3 antagonist | 0.04 0.017 DBMET00070 0.041 0.016 DBMET01181 | DBMET01181 | |
| 0.006 | 0.642 | 0.117 | HIV-1 integrase inhibitor | 0.078 0.04 DBMET01203 0.074 0.043 DBMET01204 0.076 0.042 DBMET00070 0.096 0.027 DBMET01205 0.092 0.03 DBMET01206 0.117 0.016 DBMET01180 | DBMET01180 | |
| 0.008 | 0.646 | 0.043 | Guanylate cyclase stimulant | 0.043 0.03 DBMET01180 | DBMET01180 | |
| 0.007 | 0.651 | 0.079 | Glutamate (mGluR group III) agonist | 0.079 0.013 DBMET01180 | DBMET01180 | |
| 0.022 | 0.669 | 0.239 | Tumour necrosis factor alpha release inhibitor | 0.239 0.08 DBMET01181 | DBMET01181 | |
| 0.013 | 0.666 | 0.038 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET01180 | DBMET01180 | |
| 0.009 | 0.665 | 0.255 | Pyruvate kinase inhibitor | 0.255 0.06 DBMET00070 0.206 0.078 DBMET01180 | DBMET00070 | |
| 0.052 | 0.713 | 0.15 | Cyclin-dependent kinase 3 inhibitor | 0.144 0.112 DBMET01179 0.15 0.095 DBMET01181 | DBMET01181 | |
| 0.004 | 0.667 | 0.06 | Nicotinic receptor beta4 subunit antagonist | 0.06 0.012 DBMET00070 | DBMET00070 | |
| 0.009 | 0.675 | 0.236 | Prostaglandin dehydrogenase inhibitor | 0.22 0.144 DBMET00070 0.236 0.134 DBMET01180 0.209 0.151 DBMET01181 | DBMET01180 | |
| 0.017 | 0.686 | 0.152 | Farnesoid X receptor antagonist | 0.152 0.05 DBMET01180 0.119 0.106 DBMET01181 | DBMET01180 | |
| 0.008 | 0.678 | 0.061 | Myc inhibitor | 0.061 0.028 DBMET01180 | DBMET01180 | |
| 0.004 | 0.686 | 0.117 | Factor XIa inhibitor | 0.117 0.004 DBMET01180 | DBMET01180 | |
| 0.006 | 0.691 | 0.194 | CDC25B inhibitor | 0.194 0.005 DBMET00070 0.146 0.007 DBMET01180 0.062 0.048 DBMET01181 | DBMET00070 | |
| 0.005 | 0.694 | 0.158 | Purinergic P2Y14 antagonist | 0.158 0.004 DBMET01180 0.039 0.012 DBMET01181 | DBMET01180 | |
| 0.005 | 0.695 | 0.119 | Glycogen synthase kinase-3 alpha inhibitor | 0.119 0.085 DBMET01180 | DBMET01180 | |
| 0.005 | 0.696 | 0.276 | Diuretic | 0.276 0.027 DBMET01180 | DBMET01180 | |
| 0.023 | 0.715 | 0.254 | Transcription factor inhibitor | 0.254 0.184 DBMET00070 | DBMET00070 | |
| 0.003 | 0.7 | 0.076 | Factor XI inhibitor | 0.076 0.005 DBMET01180 | DBMET01180 | |
| 0.013 | 0.711 | 0.227 | Angiogenesis stimulant | 0.227 0.081 DBMET01181 | DBMET01181 | |
| 0.015 | 0.713 | 0.213 | Hemostatic | 0.213 0.028 DBMET01180 0.188 0.038 DBMET01181 | DBMET01180 | |
| 0.014 | 0.716 | 0.121 | Potassium channel large-conductance Ca-activated activator | 0.121 0.016 DBMET01180 | DBMET01180 | |
| 0.006 | 0.715 | 0.131 | Tubulin antagonist | 0.131 0.07 DBMET00070 | DBMET00070 | |
| 0.005 | 0.717 | 0.082 | Histone deacetylase SIRT2 inhibitor | 0.082 0.044 DBMET01181 | DBMET01181 | |
| 0.023 | 0.736 | 0.096 | T cell inhibitor | 0.096 0.029 DBMET01180 | DBMET01180 | |
| 0.024 | 0.738 | 0.079 | Hematopoietic | 0.079 0.077 DBMET01180 | DBMET01180 | |
| 0.004 | 0.721 | 0.051 | Angiotensin-converting enzyme inhibitor | 0.051 0.044 DBMET01180 | DBMET01180 | |
| 0.003 | 0.725 | 0.033 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.033 0.017 DBMET01178 | DBMET01178 | |
| 0.004 | 0.726 | 0.108 | Catechol O-methyltransferase inhibitor | 0.108 0.005 DBMET00070 0.033 0.023 DBMET01205 | DBMET00070 | |
| 0.004 | 0.729 | 0.119 | NMDA 2D receptor antagonist | 0.119 0.004 DBMET01180 | DBMET01180 | |
| 0.001 | 0.731 | 0.014 | 3C-Like protease (MERS coronavirus) inhibitor | 0.014 0.005 DBMET01180 | DBMET01180 | |
| 0.011 | 0.745 | 0.23 | DNA directed DNA polymerase inhibitor | 0.23 0.205 DBMET01180 | DBMET01180 | |
| 0.005 | 0.74 | 0.161 | Alpha tubulin antagonist | 0.161 0.008 DBMET00070 | DBMET00070 | |
| 0.01 | 0.749 | 0.069 | Glutamate (mGluR8) antagonist | 0.069 0.004 DBMET01180 0.035 0.025 DBMET01181 | DBMET01180 | |
| 0.004 | 0.747 | 0.149 | Neuraminidase inhibitor | 0.149 0.006 DBMET01180 | DBMET01180 | |
| 0.005 | 0.752 | 0.16 | Glutamate receptor antagonist | 0.16 0.044 DBMET01180 | DBMET01180 | |
| 0.02 | 0.781 | 0.16 | Interleukin 4 antagonist | 0.117 0.09 DBMET01179 0.16 0.041 DBMET01180 0.112 0.098 DBMET01181 | DBMET01180 | |
| 0.028 | 0.791 | 0.211 | NOS3 expression enhancer | 0.211 0.037 DBMET01180 0.147 0.076 DBMET01181 | DBMET01180 | |
| 0.008 | 0.773 | 0.191 | Thioredoxin glutathione reductase inhibitor | 0.191 0.18 DBMET00070 0.186 0.184 DBMET01180 | DBMET00070 | |
| 0.002 | 0.776 | 0.102 | Prostaglandin EP1 antagonist | 0.102 0.004 DBMET01180 0.019 0.015 DBMET01181 | DBMET01180 | |
| 0.004 | 0.78 | 0.051 | Macrophage elastase inhibitor | 0.051 0.024 DBMET01181 | DBMET01181 | |
| 0.004 | 0.782 | 0.251 | HIV-1 integrase (3'-Processing) inhibitor | 0.063 0.044 DBMET01203 0.056 0.051 DBMET01204 0.251 0.006 DBMET00070 0.083 0.032 DBMET01205 0.071 0.038 DBMET01206 0.153 0.013 DBMET01180 0.06 0.047 DBMET01181 | DBMET00070 | |
| 0.008 | 0.786 | 0.235 | DNA polymerase beta inhibitor | 0.219 0.211 DBMET00070 0.235 0.202 DBMET01180 | DBMET01180 | |
| 0.011 | 0.79 | 0.139 | Factor IXa inhibitor | 0.139 0.004 DBMET01180 | DBMET01180 | |
| 0.004 | 0.783 | 0.109 | Pim-1 kinase inhibitor | 0.109 0.05 DBMET00070 | DBMET00070 | |
| 0.007 | 0.791 | 0.166 | Death-associated protein kinase 3 inhibitor | 0.166 0.101 DBMET01180 | DBMET01180 | |
| 0.004 | 0.788 | 0.065 | Selectin antagonist | 0.065 0.046 DBMET01181 | DBMET01181 | |
| 0.004 | 0.791 | 0.268 | Prostaglandin E2 antagonist | 0.268 0.005 DBMET01180 0.077 0.02 DBMET01181 | DBMET01180 | |
| 0.005 | 0.8 | 0.254 | Alpha-glucosidase inhibitor | 0.254 0.185 DBMET01181 | DBMET01181 | |
| 0.006 | 0.801 | 0.141 | Topoisomerase II inhibitor | 0.141 0.054 DBMET01180 0.132 0.059 DBMET01181 | DBMET01180 | |
| 0.01 | 0.809 | 0.236 | Insulin secretagoues | 0.236 0.022 DBMET01180 | DBMET01180 | |
| 0.004 | 0.809 | 0.12 | Plasminogen activator inhibitor antagonist | 0.12 0.007 DBMET01180 | DBMET01180 | |
| 0.009 | 0.819 | 0.341 | Dual specificity phosphatase inhibitor | 0.341 0.022 DBMET01180 | DBMET01180 | |
| 0.003 | 0.814 | 0.045 | Somatostatin 5 antagonist | 0.045 0.015 DBMET01180 | DBMET01180 | |
| 0.013 | 0.827 | 0.203 | Platelet adhesion inhibitor | 0.203 0.069 DBMET01181 | DBMET01181 | |
| 0.004 | 0.819 | 0.248 | Protein-tyrosine phosphatase 1B inhibitor | 0.248 0.017 DBMET01180 0.102 0.076 DBMET01181 | DBMET01180 | |
| 0.045 | 0.862 | 0.422 | Interleukin 2 agonist | 0.261 0.107 DBMET01180 0.422 0.022 DBMET01181 | DBMET01181 | |
| 0.007 | 0.824 | 0.134 | Histone deacetylase class III inhibitor | 0.134 0.058 DBMET01181 | DBMET01181 | |
| 0.004 | 0.826 | 0.158 | Neuraminidase (influenza) inhibitor | 0.158 0.007 DBMET01180 | DBMET01180 | |
| 0.005 | 0.845 | 0.337 | Protein-tyrosine phosphatase inhibitor | 0.337 0.014 DBMET01180 0.171 0.061 DBMET01181 | DBMET01180 | |
| 0.007 | 0.851 | 0.329 | Amyloid beta precursor protein antagonist | 0.329 0.012 DBMET01180 | DBMET01180 | |
| 0.004 | 0.85 | 0.242 | HIV-1 integrase (Strand Transfer) inhibitor | 0.242 0.007 DBMET00070 0.055 0.045 DBMET01205 0.135 0.014 DBMET01180 | DBMET00070 | |
| 0.01 | 0.859 | 0.157 | Thioredoxin inhibitor | 0.157 0.015 DBMET00070 0.103 0.045 DBMET01181 | DBMET00070 | |
| 0.003 | 0.855 | 0.037 | Prostacyclin antagonist | 0.037 0.02 DBMET01180 0.03 0.025 DBMET01181 | DBMET01180 | |
| 0.007 | 0.871 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.12 0.025 DBMET00070 0.138 0.018 DBMET01180 | DBMET01180 | |
| 0.004 | 0.873 | 0.382 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.382 0.028 DBMET00070 0.148 0.132 DBMET01180 | DBMET00070 | |
| 0.004 | 0.874 | 0.347 | Dyrk kinase inhibitor | 0.347 0.038 DBMET00070 | DBMET00070 | |
| 0.008 | 0.879 | 0.134 | M18 aspartyl aminopeptidase inhibitor | 0.129 0.064 DBMET01205 0.119 0.072 DBMET01206 0.134 0.061 DBMET01180 | DBMET01180 | |
| 0.003 | 0.877 | 0.076 | DNA-dependent protein kinase inhibitor | 0.076 0.01 DBMET00070 | DBMET00070 | |
| 0.002 | 0.88 | 0.039 | Kainate receptor 4 antagonist | 0.039 0.01 DBMET00070 | DBMET00070 | |
| 0.004 | 0.891 | 0.091 | DNA gyrase inhibitor | 0.091 0.021 DBMET01180 | DBMET01180 | |
| 0.006 | 0.893 | 0.039 | Purinergic P2Y2 antagonist | 0.039 0.016 DBMET01180 | DBMET01180 | |
| 0.004 | 0.893 | 0.117 | Cyclooxygenase 2 inhibitor | 0.117 0.083 DBMET01180 | DBMET01180 | |
| 0.002 | 0.892 | 0.034 | Kainate receptor 5 antagonist | 0.026 0.011 DBMET00070 0.034 0.008 DBMET01180 | DBMET01180 | |
| 0.005 | 0.9 | 0.237 | Streptokinase A inhibitor | 0.237 0.111 DBMET01180 | DBMET01180 | |
| 0.005 | 0.901 | 0.14 | Cyclooxygenase inhibitor | 0.14 0.078 DBMET01180 0.113 0.107 DBMET01181 | DBMET01180 | |
| 0.004 | 0.904 | 0.09 | Cell adhesion molecule inhibitor | 0.09 0.043 DBMET01180 | DBMET01180 | |
| 0.006 | 0.908 | 0.084 | Breast cancer-resistant protein inhibitor | 0.084 0.073 DBMET01180 | DBMET01180 | |
| 0.003 | 0.905 | 0.037 | Protocollagen prolyl hydroxylase inhibitor | 0.037 0.009 DBMET01180 | DBMET01180 | |
| 0.005 | 0.91 | 0.138 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.138 0.132 DBMET00070 | DBMET00070 | |
| 0.003 | 0.91 | 0.062 | Aldose reductase inhibitor | 0.062 0.031 DBMET01180 | DBMET01180 | |
| 0.012 | 0.92 | 0.179 | MAP3K9 inhibitor | 0.179 0.027 DBMET01181 | DBMET01181 | |
| 0.022 | 0.93 | 0.145 | MAP kinase kinase 4 inhibitor | 0.145 0.072 DBMET01180 | DBMET01180 | |
| 0.004 | 0.913 | 0.11 | Phosphodiesterase 3A inhibitor | 0.11 0.026 DBMET01181 | DBMET01181 | |
| 0.005 | 0.914 | 0.346 | Dual specificity phosphatase 3 inhibitor | 0.346 0.021 DBMET01180 | DBMET01180 | |
| 0.004 | 0.916 | 0.089 | HIV-1 reverse transcriptase inhibitor | 0.089 0.036 DBMET00070 | DBMET00070 | |
| 0.005 | 0.924 | 0.488 | Cyclophilin D inhibitor | 0.46 0.063 DBMET01180 0.488 0.054 DBMET01181 | DBMET01181 | |
| 0.004 | 0.929 | 0.153 | Cyclooxygenase 1 inhibitor | 0.153 0.055 DBMET01180 0.136 0.066 DBMET01181 | DBMET01180 | |
| 0.005 | 0.934 | 0.107 | DNA directed RNA polymerase inhibitor | 0.107 0.049 DBMET01178 | DBMET01178 | |
| 0.005 | 0.935 | 0.027 | Granulocyte colony stimulating factor receptor agonist | 0.027 0.004 DBMET00070 | DBMET00070 | |
| 0.004 | 0.942 | 0.425 | Mcl-1 antagonist | 0.165 0.077 DBMET00070 0.425 0.009 DBMET01180 0.123 0.121 DBMET01181 | DBMET01180 | |
| 0.005 | 0.943 | 0.074 | Autotaxin inhibitor | 0.074 0.021 DBMET01180 | DBMET01180 | |
| 0.003 | 0.943 | 0.05 | Phosphodiesterase 3B inhibitor | 0.05 0.025 DBMET01181 | DBMET01181 | |
| 0.006 | 0.954 | 0.059 | Carnitine palmitoyltransferase 1B inhibitor | 0.059 0.018 DBMET01180 | DBMET01180 | |
| 0.005 | 0.953 | 0.133 | Cell adhesion inhibitor | 0.133 0.057 DBMET01180 | DBMET01180 | |
| 0.005 | 0.957 | 0.328 | Hypoglycemic | 0.265 0.068 DBMET01180 0.328 0.043 DBMET01181 | DBMET01181 | |
| 0.004 | 0.958 | 0.198 | Bronchodilator | 0.198 0.018 DBMET01181 | DBMET01181 | |
| 0.004 | 0.965 | 0.148 | Thrombolytic | 0.148 0.083 DBMET01180 | DBMET01180 | |
| 0.004 | 0.965 | 0.051 | DNA gyrase subunit A inhibitor | 0.051 0.016 DBMET01180 | DBMET01180 | |
| 0.004 | 0.967 | 0.184 | Platelet antagonist | 0.184 0.114 DBMET01180 | DBMET01180 | |
| 0.003 | 0.981 | 0.073 | Nicotinic acid receptor 1 agonist | 0.073 0.012 DBMET01180 | DBMET01180 | |
| 0.008 | 0.991 | 0.086 | Interleukin 12 antagonist | 0.086 0.082 DBMET01181 | DBMET01181 | |
| 0.003 | 0.987 | 0.194 | M17 leucyl aminopeptidase inhibitor | 0.194 0.035 DBMET01180 | DBMET01180 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |